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List of abbreviations 
ANA domain   ANAphylatoxin domain 
APC   AlloPhycoCyanin 
BMDCs   Bone Marrow derived Dendritic Cells 
CCL19   Chemokine (C-C motif) Ligand 19 
CCR7   C-C Chemokine Receptor type 7 
cDC   Conventional or Classical Dendritic Cell 
CDC42   Cell Division Control protein 42 homolog 
CFTR   Cystic Fibrosis Transmembrane conductance Regulator  
CLP   Common Lymphoid Progenitor, 
CMP   Common Myeloid Progenitor 
CR3   Complement Receptor type 3 (CD11b/CD18, αMβ2, Mac-1) 
CR4   Complement Receptor type 4 (CD11c/CD18, αxβ2, p150,95) 
CUB domain  Complement C1r/C1s, Uegf, Bmp1-fold containing domain 
DCs   Dendritic Cells 
ECM   ExtraCellular Matrix 
EDTA   EthyleneDiamineTetraacetic Acid 
FCS   Fetal Calf Serum 
FHP   Filamentous Hemagglutinin Protein 
FITC   Fluorescein IsoThioCyanate 
fMLP   N-FormylMethionyl-Leucyl-Phenylalanine 
FPR   Formyl Peptide Receptors 
GM-CSF  Granulocyte-Macrophage Colony-Stimulating Factor  
GTP/GDP  Guanosine TriPhosphate/ Guanosine DiPhosphate   
HBSS   Hanks' Balanced Salt Solution 
ICAM-1   Intercellular Adhesion Molecule 1 
I-EGF domain  Integrin-Epidermal Growth Factor 
IFNγ   InterFeroNγ 
IL   InterLeukin 
iNOS   inducible Nitric Oxide Synthase 
JAM   Junctional Adhesion Molecule 
KO   Knock Out 
LAD   Leukocyte Adhesion Deficiency 
LFA-1 Lymphocyte Function-associated Antigen 1 (CD11a/CD18, 
αLβ2) 
LPS   LipoPolySaccharide 
mAb   Monoclonal AntiBody 
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MDDC   Monocyte Derived Dendritic Cell 
MDM   Monocyte Derived Macrophage 
MFI   Mean Fluorescence Intensity 
MG domain  MacroGlobulin domain 
MIDAS   Metal-Ion-Dependent Adhesion Site 
Mo   Monocyte 
NET   Neutrophil Extracellular Trap 
Neu   Neutrophil granulocyte 
NIF   Neutrophil Inhibitory Factor 
NK cell   Natural Killer cell 
PBMC   Peripheral Blood Mononuclear Cells 
PBS   Phosphate Buffered Saline solution 
PDB   Protein Data Bank 
pDC   Plasmacytoid Dendritic Cells 
PLL-g-PEG synthetic copolymer Poly(L-Lysine)-Graft-Poly(Ethylene 
Glycol) 
PMN   PolyMorphoNuclear cell 
PNRC   PeriNuclear Recycling Compartment 
PSI domain  Plexin-Semaphorin-Integrin domain 
Rap1   Ras-proximate-1 
RGS14   Regulator of G-Protein Signalling-14 
RhoA   Ras HOmolog gene family, member A  
RIAM   Rap1-Interacting Adaptor Molecule 
ROI   Region Of Interest 
RT   Room Temperature 
siRNA   Small Interfering RiboNucleic Acid 
SLE   Systemic Lupus Erythematosus  
SNP   Single Nucleotide Polymorphism 
TED domain   ThioEster-containing Domain  
TGF-β   Transforming Growth Factor β 
TIP-DC   TNF- and iNOS-producing dendritic cells 
TLR   Toll-Like Receptor 
TNF-α   Tumour Necrosis Factor 
uPAR   Urokinase Receptor 
VCAM   Vascular Cell Adhesion Molecule 




The complement receptors CR3 (CD11b/CD18, also known as Mac-1; αMβ2) and CR4 
(CD11c/CD18, also known as p150,95; αXβ2) belong to the family of β2-integrins and play 
an important role in phagocytosis, cellular adherence and migration. Their natural ligands 
include the iC3b complement component on opsonised targets, and fibrinogen or ICAM-1 
as adhesion ligands1–3. The ligand binding affinity of integrins is regulated by activation 
dependent conformational changes. Their extracellular domains undergo remarkable 
structural rearrangements to switch from a bent, inactive state into an extended, ligand-
binding conformation.  
A similar role is often assumed for CR3 and CR4 since they have an overlapping 
ligand binding specificity and high sequence homology (87%) in their extracellular 
domains4. However, their intracellular parts, important for signal transduction and 
connection with the cytoskeleton, differ in length and amino acid sequence displaying only 
a 56% similarity5. Our group set out to thoroughly investigate the individual role of CR3 and 
CR4, since studies published on these receptors reveal a pivotal role for them in leukocyte 
functions necessary for the resolution of infections6. 
 
1.1. The expression and endosomal recycling of CR3 and CR4 
The expression of CR3 and CR4 varies between cell types and species6. In humans 
both receptors can be found on myeloid cells, such as neutrophil granulocytes, monocytes, 
macrophages and dendritic cells7–9. In mouse CR4 has a high expression level only on 
dendritic cells and it additionally appears on certain subpopulations of monocytes, 
macrophages and neutrophils10–13. On lymphoid cells they are not expressed uniformly, only 
NK cells express CR3 constitutively14,15. On T and B lymphocytes these receptors are 
usually present on subpopulations15, appear after activation16,17 or during pathological 
conditions18,19.  
Our group recently assessed the absolute number of cell surface CR3 and CR4 on 
human monocytes, neutrophils, monocyte-derived macrophages (MDM) and monocyte-
derived dendritic cells (MDDC)6,8. These data reveal that the expression level of the two 
receptors differs among these cell types. Comparing the number of CR3 and CR4 on the 
same cell type there is a strong shift in favour of CR3 in the case of monocytes and 
neutrophils, whereas on MDMs and MDDCs the CD11b:CD11c ratio is close to 1:1. The 
notable differences in receptor number probably contribute to the functional diversity 
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observed in the case of different immune cells. The ratio of these receptors in conjunction 
with ligand availability may influence the competition between these receptors, determining 
the outcome of the interactions.  
The availability of integrins is regulated by continuous receptor trafficking. Instead of 
degradation, they are rapidly recycled between the cell membrane and endosomes20. This 
mechanism extends the lifetime of integrins, for instance Lobert et al. showed a half-life of 
12-24 hours for the α5β1-integrin21. Both clathrin-dependent and -independent ways were 
described for the endocytosis of integrins22, and the Rab family of small GTPases mediate 
the trafficking of membrane vesicles23. For integrins, this rapid recycling can occur via 
distinct routes24,25. The αVβ3- and inactive β1-integrins were shown to cycle through a short, 
Rab4-dependent pathway, where these receptors are quickly returned to the plasma 
membrane from the early endosomes20,26. In the Rab11-dependent long loop, first described 
for β1-integrins, receptors go through the perinuclear recycling compartment (PNRC) before 
returning to the cell surface26,27. The fast recycling of integrins grants constantly new 
receptors for ECM engagement, providing environmental information and efficient 
migration.  
There are few data available on the recycling route used by β2-integrins. In the 
cytoplasmic domain of the LFA-1 (CD11a/CD18, αLβ2) β chain Fabbri et al. found a 
membrane proximal sequence that is required for recycling28, and later proved a clathrin-
independent and Rab11 mediated route for this molecule29. In an older publication by 
Bretscher, studying various cell lines, a high recycling rate was shown for CR3 in contrast 
to LFA-1, that has a very low, or no internalization20. This difference suggests an α-chain 
based regulation, prompting the necessity for further research in this field. 
 
1.2. The structural and signalling properties of CR3 and CR4 
Integrins are transmembrane heterodimers, consisting of a non-covalently coupled α 
and β chain. They have a large extracellular region for ligand binding, a transmembrane 
domain and a short cytoplasmic tail, interacting with signalling molecules and the actin 
cytoskeleton30,31.  The α subunit head consists of a β-propeller and I-domain (Inserted) and 
it is connected to an elongated leg region, including three domains with a β-sheet structure, 
the thigh, calf-1 and calf-232. The β subunit head is formed by an I-like domain and the leg 
includes a PSI (plexin-semaphorin-integrin) domain, a hybrid domain, four I-EGF (integrin-





Figure 1. The affinity regulation of β2-integrins. The ligand binding affinity of integrins is 
regulated by activation dependent conformational changes. Integrins can convert between 
an inactive bent and an activated extended conformation. Both subunits are bent in the 
inactive form, positioning the head domains near the cell membrane. Inside-out signalling 
results in the extended conformation, orienting the I-domain away from the membrane. 
Ligand binding to the activated integrin triggers the outside-in signalling pathway, 
recruiting various cytosolic proteins. The combination of a lateral force exerted by the actin 
cytoskeleton and the resistance provided by the bound ligand stabilizes the high affinity, 
open state. The X-ray diffraction data of CR4 was used from PDB entry 5ES435 and the 
structure was visualized with PyMOL software. The transmembrane and cytoplasmic 
domains are not shown.  
 
Integrins can be divided into two large groups by their head region composition, 
integrins which have the αI-domain and those that do not. Integrins lacking an αI-domain 
bind their ligands with the interaction of the βI-like domain and the β-propeller domain from 
the α subunit36. Where it is present, the αI-domain is responsible for ligand recognition. The 
α chains coupled to the β2 subunit have an I-domain, and it is indeed the recognition site for 
their most known ligands, like iC3b, fibrinogen and ICAM-11,37,38. The ligand binding occurs 
at the metal-ion-dependent adhesion site (MIDAS) and it is dependent on the presence of a 
bivalent cation39. The MIDAS is formed by a conserved DxSxS motif and two non-
contiguous amino acids in the αI-domain, and from the ligand, an acidic residue takes part 
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in the coordination of the metal ion31,40,41.   
The ligand binding affinity of integrins is regulated by activation dependent 
conformational changes. Integrins can transition between an inactive bent and an activated 
extended conformation42. Both subunits are bent in the inactive form, positioning the head 
domains near the cell membrane. The α subunit bends between the thigh and calf-1 domains, 
termed genu, and the β2 subunit between the I-EGF1 and I-EGF2 domains43,44. The close 
interactions of the α and β transmembrane and cytoplasmic domains keep integrins in the 
inactive state, to have an active conformation, these regions must be separated. This 
activation is achieved by molecules, most importantly talin, connecting integrins to the actin 
cytoskeleton. Talin interacts with the β tail in a membrane proximal region and at a 
conserved NPxY/F motif (NPLF in β2) found in the mid section of the cytoplasmic region 
(between the 747th-755th residues)45–49. The binding of talin to the membrane proximal 
region disrupts the association of the α and β tails and initiates the separation of the 
transmembrane domains50,51. 
Within the headpiece, a low affinity closed, a high affinity open and an intermediate 
conformation in between can be distinguished52–54.  The affinity regulation is in association 
with the conformation changes of loops containing the residues that coordinate ligand 
binding at the MIDAS region41,42,55. The extension of the integrin legs enables a swing out 
movement for the PSI and hybrid domains, inducing the conformational changes in the I 
domain required for a high affinity, open state56–58.  However, in an extended integrin both 
open and closed conformation was shown to exist, and ligand binding and tensile force play 
a crucial role in determining the headpiece position. The combination of a lateral force 
exerted by the actin cytoskeleton and the resistance provided by the bound ligand stabilizes 
the high affinity, open state59,60. At the uropod, where actin depolymerisation takes place 
and the integrins are no longer attached to the cytoskeleton, the tensile force  applied by the 
retracting membrane promotes detachment from the ligand by stabilizing the low affinity, 
closed conformation61,62.  
A small GTPase Rap1 (Ras-proximate-1) was shown to participate in the talin 
dependent inside-out activation of LFA-163 and CR364,65. RIAM (Rap1-interacting adaptor 
molecule) was proposed as a scaffold between Rap1 and talin, given its ability to bind both 
molecules66,67. Macrophages and neutrophils from RIAM deficient mice show disrupted β2-
integrin dependent adhesion and spreading68. Using the human THP-1 monocytic cell line, 
Lim et al. found, that siRNA silencing of RIAM did not impair phagocytosis and spreading65, 
instead later showed a role for the Regulator of G-Protein Signalling-14 (RGS14) in the 
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activation of CR3 during phagocytosis in the murine J774.A1 cell line69. However Medraño-
Fernández et al. proved later, that RIAM is important for complement mediated phagocytosis 
for HL-60 and THP-1 cell lines and human monocyte derived macrophages70. Data obtained 
from the KO mice models suggest, that RIAM might be β2-integrin specific, as the function 
of platelet αIIbβ3-integrin71 and β1-integrins on PMNs68 is not disrupted in these mice. 
Additionally, talin deficient mice show a more severe phenotype compared to RIAM KO 
mice68, underlining that the absence of talin effects the function of all integrins, but the 
absence of RIAM not.  
 
1.3. The diverse ligands bound by CR3 and CR4 
The many ligands described for CR3 and CR4 proved a promiscuous binding ability, 
with no apparent common motif in these molecules (Table 1.). Their ligands include 
complement proteins, ECM components and adhesion molecules, all recognised by the 
major ligand binding site in the αI-domain1. The β-glucan components of fungal cells are 
recognized by a separate lectin site in CR3, located C-terminally from the I-domain72. An 
also I-domain independent binding site for bacterial lipopolysaccharides was shown as well 
in both CR3 and CR473,74.  
 
 CR3 CR4 
Complement proteins iC3b1, Factor H75 iC3b76, Factor H77 











Neutrophil inhibitor factor 
(NIF)91, FHP92 
LPS74, Rotavirus93 
Table 1. The ligands of CR3 and CR4 
 
The first identified, natural ligand for CR3 and CR4 was the iC3b complement 
component76. This component is generated by the cleavage of surface bound C3b, deposited 
on complement activating surfaces. Although the iC3b molecule does not allow further 
complement activation, it serves as a potent opsonin recognized by complement receptors94. 
Mapping the binding sites for CR3 and CR4 revealed that these receptors bind different 
residues in iC3b95. The binding sites are illustrated on C3b on Figure 2., in the absence of a 
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resolved structure for iC3b. From the crystal structure of an C3d:αMI-domain complex Bajic 
et al. described the amino acid residues in CR3 (Ser142, Ser144, Thr209) and the C3 TED 
domain (Lys1217, Asp1245, Asp1247, Arg1254) participating in the coordination of the 
bivalent cation 38. According to a study by Chen et al, CR4 can not bind to the TED domain 
of iC3b, but instead it recognises a sequence in the MG3-MG4 interface96. Using electron 
microscopy, Xu et al. verified these results, and discovered an additional binding site for 
CR4 near the C345C domain95. A different binding site for CR3 and CR4 could enhance the 




Figure 2. The crystal structure of C3 and C3b with the binding sites for CR3 and CR4 
The C3 component (A) consists of two chains, α and β. The β chain contains the first five 
macroglobulin (MG1-5) domains and the MG6 domain is formed by the intertwined strands 
of both the α and β chain. The α chain starts with the anaphylatoxin (ANA) domain, that is 
cleaved during complement activation. It is followed by the MG7 and CUB domain. The C3b 
molecule (B) is covalently bound on the activating surface through the thioester-containing 
domain (TED), where the reactive moieties emerge only after the cleavage of C3a (ANA 
domain). The α chain ends with MG8 and the C345C domain94.  The X-ray diffraction data 





Another natural ligand of these receptors is fibrinogen, that is known as an indicator 
of tissue damage. The best known role of this molecule is maintaining hemostasis by the 
formation of fibrin clots at the site of vessel wall injuries. It is an acute phase protein, with 
an elevated hepatic and extrahepatic expression during inflammation, resulting in a higher 
circulating concentration in blood98. During injury fibrinogen is deposited both 
intravascularly and into the extracellular matrix in the surrounding tissues99. There is an 
increasing amount of evidence that this process also functions as an inflammatory stimulus 
for platelets and leukocytes100,101.  
Fibrinogen is and elongated hexamer, consisting of three pairs of peptide chains: 2 Aα, 
2 Bβ and 2 γ (Fig. 3). The outer D-domains are connected by coiled-coil segments to the 
central E-nodule, where the chains are linked by five disulphide bridges102. The first studies 
applying monoclonal antibodies specific for the CD11b I-domain identified CR3 on 
monocytes and neutrophils as a receptor for fibrinogen78,103. Using synthetic peptides the 
binding site for CR3 was mapped to the C-terminal domain of the γ chain104,105. From the 
two potential binding sequences γ190-202 (P1) and γ377-395 (P2), P2 was proved to contain 
the required recognition motif NRLTIG at γ390-395106,107. The binding of the P1 and P2 
sequences were shown for CR4 as well108, but several groups proved another binding site at 
the central E region of fibrinogen37,80,109.  Loike et al. proposed the N-terminal 17-19 amino 
acids of the Aα chain for the binding site, as peptides containing this sequence inhibited the 
adhesion of neutrophils to the central nodule80.  
The binding sites in fibrinogen are cryptic in the native protein, and are only exposed 
upon proteolysis and immobilization110. Consequently, the soluble protein does not activate 
cells in the circulation, the proinflammatory effect is regulated by its deposition at the site 
of injury. Fibrinogen accumulates only in the inflamed tissues, marking it for the recruitment 
of leukocytes. The engagement of fibrinogen via CR3 and CR4 enhances antimicrobial 





Figure 3. The structure of human fibrinogen. The elongated fibrinogen hexamer consists 
of three pairs of peptide chains 2Aα, 2Bβ and 2γ. CR3, and possibly CR4, recognise a 
NRLTIG motif in the γ chain, and there is an additional binding site for CR4 at the N-
terminus of the Aα chain. The outer globular parts are called D-domains, and the central 
nodule is termed E-domain. The X-ray diffraction data was used from PDB entry 3GHG111 
and the structure was visualized with PyMOL software.  
 
 
1.4. The function of CR3 and CR4 in myeloid cells 
CR3 and CR4 are known to play an essential role in cell motility and the elimination 
of pathogens via phagocytosis. Immune cells expressing these receptors will migrate through 
the endothelium and move in the direction of infection within the tissues. This is achieved 
with the help of podosomes, providing the surface for integrin-ligand connections. Innate 
immune cells will be the first to engage the invading pathogens, and to capture and 
internalize targets, these cells utilize a range of receptors. Pattern recognition receptors bind 
the pathogens directly, while complement or IgG opsonized targets become recognizable by 
complement- and Fc-receptors, significantly increasing the efficiency of phagocytosis112,113. 
Additionally, these cells have receptors dedicated to sense the signs of danger, like bacterial 
products, the anaphylatoxic complement fragments C3a and C5a or chemokines produced 
by tissue resident cells114,115. N-formylated oligopeptides originating from the invading 
bacteria or released by the mitochondria due to tissue damage are recognised by formyl 
peptide receptors (FPRs)116. These receptors are expressed on neutrophils, monocytes, 
macrophages and immature dendritic cells117–119, and have an important role in initiating the 
immune response by promoting leukocyte recruitment, enhanced phagocytosis and the 





Figure 4. The ontogenesis of granulocytes, monocytes, macrophages and dendritic 
cells. Granulocytes, monocytes and conventional dendritic cells develop from the common 
myeloid progenitor cell through lineage committed precursors (not shown in this figure), 
and plasmacytoid dendritic cells differentiate from the common lymphoid progenitor. 
Monocytes migrate into the tissues, where they repopulate the pool of resident macrophages. 
When monocytes are recruited to sites of inflammation, they differentiate into monocyte 
derived cells with an activated phenotype. The figure was based on the handbook: Anna 




Myeloid cells originate from the common myeloid progenitor (CMP) lineage of the 
hematopoietic stem cells in the bone marrow (Fig. 4). Granulocytes have three major 
populations that were first distinguished based on their histological staining: neutrophils, 
basophils and eosinophils. Basophil and eosinophil granulocytes comprise only a small 
percent of leukocytes in the blood and their best known functions are mediating allergic 
reactions and defence against parasites, respectively122,123. Neutrophil granulocytes give 50-
70% of circulating leukocytes and these cells are the first to migrate to the site of injury in 
large numbers. They bear numerous pattern recognition and phagocytic receptors, as well as 
granules containing proteases and anti-microbial peptides124. Additionally, upon activation 
neutrophils can release a mixture of nuclear DNA and enzymes, called the neutrophil 
extracellular trap (NET)125. Thus neutrophils quickly and effectively eliminate pathogens 
through phagocytosis and NET release. 
In humans, monocytes are divided into 3 groups based on the expression of CD14 and 
CD16: classical (CD14+ CD16-), intermediate (CD14+ CD16+) and non-classical (CD14low 
CD16+)126. Classical monocytes stay in the circulation for one day after exiting the bone 
marrow, then migrate into tissues to repopulate the pool of resident macrophages127. Recent 
fate mapping studies in mice revealed that only a small population of tissue resident 
macrophages differentiates from monocytes, but instead most subsets are embryonic in 
origin with the capacity for self-renewal128. During inflammation, classical monocytes are 
quickly recruited to the site of injury, where they directly exert proinflammatory functions 
as “inflammatory monocytes” or differentiate into monocyte derived cells129,130. These 
monocytes show great plasticity during maturation, the phenotype of monocyte derived 
macrophages and dendritic cells (or TIP-DCs) strongly depends on the tissue 
microenvironment131,132. Non-classical monocytes comprise 10% of blood monocytes, and 
can also differentiate from classical monocytes, through the intermediate phenotype133. 
These monocytes have a longer circulating time of approximately 7 days, during which they 
monitor the integrity of blood vessels via an LFA-1 mediated crawling on the 
endothelium134,135. Non-classical monocytes were also associated with a proinflammatory 
phenotype, that could contribute to disease progression136,137.  
Specialized populations of resident macrophages can be found in most tissues over the 
body: alveolar macrophages in the lungs, microglia in the brain, osteoclasts in the bone, 
Kupffer cells in the liver, marginal zone and sinus macrophages in the lymphoid organs138. 
Their characteristic gene expression profile and function is defined by the local 
microenvironment, which contributes to specific tissue homeostasis139,140. The common 
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features of all macrophage subpopulation are the recognition and elimination of pathogens, 
the advancement of the immune response through cytokine secretion and antigen 
presentation and lastly, the promotion of tissue repair and regeneration. During immune 
surveillance, macrophages sense the possible danger signals in the environment, which 
induces their activation. The traditional classification of activated macrophages includes the 
classically activated M1 and the alternatively activated M2 macrophages. The M1 
polarization is induced by IFN-γ, TNF-α or bacterial products, like lipopolysaccharide 
(LPS), resulting in a proinflammatory phenotype141. These macrophages secrete high levels 
of proinflammatory cytokines, reactive oxygen species, contributing to an effective pathogen 
elimination and consequent tissue damage142. The presence of IL-4, IL-13 or IL-10 cytokines 
supports the development of M2 macrophages, that is characterized by its anti-inflammatory 
properties. They produce IL-10 and TGF-β, phagocytose debris and apoptotic cells and help 
tissue regeneration143,144. It is important to mention, that this strict dichotomy is the 
simplification of macrophage activation, that can vary on a wide spectrum depending on the 
activating stimulus and the microenvironment145. Instead of using the terms M1 and M2 
macrophages, researchers studying macrophage activation should always state the activating 
conditions in their experiments146. 
Dendritic cells are known for their importance as antigen presenting cells and in the 
initiation of adaptive immune responses. They can differentiate from both the common 
lymphoid (CLP) and myeloid (CMP) progenitor, giving rise to plasmacytoid (pDC) and 
conventional (cDC) dendritic cells, respectively. pDCs have a lower expression of 
costimulatory and MHCII molecules than cDCs and a limited potential to prime naïve T-
cells147,148. They secrete high amounts of type I interferons upon TLR7 and TLR9 ligation 
with nucleic acids, providing an effective immune defence against viral infections149. 
Conventional dendritic cells reside in both lymphoid and non-lymphoid tissues in an 
immature state, where they continuously monitor their environment. They maintain 
tolerance by presenting self-antigens and initiate an immune response upon encountering 
foreign ones12. Immature dendritic cells have a high phagocytic capacity to internalize 
pathogens, but the proteolytic degradation of antigens is more restricted than in 
macrophages. The lower concentration of lysosomal enzymes and a higher pH in the 
endosomes could contribute to the preservation of antigens for presentation150. Dendritic 
cells migrate to the lymph nodes after antigen uptake, and during this journey they go 
through a maturation process151. Maturation induces functional changes including 
chemokine receptor and costimulatory molecule expression and the rearrangement of the 
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actin cytoskeleton. The chemokine receptor CCR7 is upregulated during maturation and 
migration to the T-cell area is directed by the stromal cell produced CCL19 and CCL21. 
Concomitantly, dendritic cells lose their capacity for phagocytosis and become potent 
activators of naïve T-cells.  
Myeloid cells populate the possible entry points in the tissues and provide the first line 
of defence against invading pathogens. They are involved in the quick elimination of 
microbes and in the initiation and regulation of adaptive immune responses. Human myeloid 
cells express CR3 and CR4 in high numbers, which receptors are essential in these processes. 
Studying the role of these receptors could take us closer to understand these basic immune 
cell functions. 
 
1.4.1. The role of CR3 and CR4 in adherence and podosome formation 
CR3 and CR4 are known to mediate cell adhesion, spreading and migration through 
the establishment of cell-cell and cell-extracellular matrix connections30. Most publications 
only discuss in detail the functions of LFA-1 and CR3, and the commonly used mouse 
models are either CD11b- or CD18-deficient152,153. However, studies on human granulocytes 
and monocytes showed that LFA-1, CR3 and CR4 all contribute differently to endothelial 
adhesion154,155. These studies also demonstrate that the cell type and the stimuli used can 
influence the participation of these receptors. Thacker and Retzinger showed, that human 
monocyte derived dendritic cells bind to fibrinogen, that stimulates the secretion of  
cytokines in a CD18-dependent manner, however they could not discriminate between the 
specific receptors156. Georgakopoulos et al showed, that CR3 and CR4 contribute differently 
to adhesion on fibrinogen and their participation is dependent on the experimental 
conditions, namely the type of stimuli and culture conditions of human blood monocytes157.   
Immune cells of the monocytic lineage use specific adhesive structures for cell 
adhesion and migration, called podosomes. Podosomes are known to mediate short-lived 
adhesion spots that are formed and quickly remodelled during migration. Cell movement can 
be achieved with podosome disassembly at the uropod and formation at the leading edge158. 
The first studies describing these structures showed an F-actin core and an adhesion ring 
surrounding it on the contact surface of adherent cells (Fig. 5)159–161. High-resolution 
microscopy helped to understand the ultrastructure of podosomes, revealing that instead of 
a continuous ring, integrins are positioned in small islets around the core162. The core is built 
up from branched actin fibers, surrounded by unbranched antiparallel contractile filaments 
reaching the site of adhesion163. This contractility contributes to the mechanosensory 
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function of podosomes in the detection of matrix rigidity164. Additionally, individual 
podosomes are connected with each other through actomyosin filaments, regulating their 
distribution and synchronized function165. These data suggest a complex network of adhesive 
structures that is achieved with the cooperation of individual podosomes and local actin 
polymerization. 
The importance of β2-integrins in podosome formation and podosome mediated 
adhesion has been proven, but the individual role of these receptors had not been studied so 
far. Burns et al. found, that β2-integrins are specifically recruited to podosomes in human 
MDDCs on a fibronectin surface (a ligand for both β1- and β2-integrins), whereas β1- 
integrins show a disperse distribution166. In a β2-integrin-null mouse model, Gawden-Bone 
et al. showed that in the absence of β2-integrins podosome assembly is disrupted167. With the 
development of super-resolution techniques more and more podosome associated molecules 
are described. Studying the individual role of these proteins in detail, such as integrins, is 
indispensable for the understanding of podosome function. 
 
 
Figure 5. The structure of podosomes. Podosomes are found in the contact surface of 
adherent cells. These structures have an F-actin core surrounded by an adhesion ring, and 
can be visualized by staining the actin cytoskeleton with a fluorophore conjugated phalloidin 
probe (shown in green). Cell nuclei were stained with Draq5 DNA dye (in red). 
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1.4.2. The role of CR3 and CR4 in phagocytosis 
Well accepted role of CR3 and CR4 are the phagocytosis of opsonized pathogens, 
tumour- and apoptotic cells. In the literature however, the participation of these receptors is 
not consistent. It seems to depend on the cell types and the experimental conditions applied 
in these experiments. The outcome is also affected by the microbe used to study 
phagocytosis, since some pathogens are able to utilize complement receptors for the 
infection of host cells168,169, and CR3 and CR4 was shown to directly bind bacterial or viral 
components as well92,93.  
Experiments employing human monocytes proved a more prominent role for CR3 in 
the phagocytosis of opsonized Mycobacterium leprae170, Borrelia burgdorferi171 and 
Plasmodium falciparum infected erythrocytes172, and no significant contribution of CR4 to 
the CR3 mediated uptake of Mycobacterium tuberculosis173 and Staphylococcus aureus174 
was found.  
Neutrophils also preferentially use CR3 over CR4 for serum-mediated phagocytosis 
of Francisella tularensis175 and this receptor is also involved in the nonopsonic phagocytosis 
of Salmonella enterica176 or Mycobacterium kansasii177.  
In the case of human macrophages, the role of CR3 and CR4 in phagocytosis could be 
influenced by the subset of these cell types and the invading pathogen they encounter. Both 
CR3 and CR4 were shown to be involved in the binding and/or phagocytosis of opsonised 
Cryprococcus neoformans178, Mycobacterium leprae179 and Francisella tularensis175 by 
MDMs. However, in alveolar macrophages CR4 was shown to be the major receptor in the 
uptake of Mycobacterium tuberculosis173.   
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1.5. The pathological implications of CR3 and CR4 
Ailments caused by the deficiency of β2-integrins shed light on their importance in the 
resolution of infections. The absence or malfunction of these receptors have functional 
consequences, affecting both innate and adaptive immunity.  
Leukocyte adhesion deficiency (LAD) is a rare autosomal recessive disorder first 
described almost 40 years ago. The symptoms for these patients are recurrent bacterial and 
fungal infections and impaired wound healing, as a consequence of reduced leukocyte 
adherence and recruitment180. This deficiency has several types, with all forms of mutations 
affecting a step in the cell adhesion cascade181. LAD-I is caused by a variety of mutations in 
the ITGB2 gene, coding the β2-integrin subunit182. Patients having the mutated gene show 
reduced expression of all β2-integrins, including LFA-1, CR3 and CR4180. The position of 
the mutation influences the severity of the disease, with moderately deficient cases 
expressing 5-10% of normal β2-integrin levels, and the more severe cases expressing less 
than 1%183,184. Neutrophils and mononuclear cells from LAD-I patients fail to adhere and to 
migrate to the site of inflammation, and show defects in the phagocytosis of complement 
opsonized particles184–187. LAD-II is linked to the mutation of the Golgi-localised GDP-
fucose transporter, important for the posttranslational fucosylation of selectin ligands188. In 
the absence of functional selectin ligands, leukocytes fail to stick and roll on the blood 
vessels, a motion that initiates adhesion185. LAD-III is caused by a mutation in the Kindlin-
3 gene, which is crucial for the activation of β1-, β2- and β3-integrins. These receptors are 
expressed in normal levels on leukocytes and platelets of LAD-III patients, but they stay in 
an inactive state189. Besides the symptoms caused by deficient adherence described in LAD-
I, patients with LAD-III also show severe bleeding tendencies, as the aggregation of platelets 
is impaired without functional β3-integrins190. A fourth type of adhesion deficiency (LAD-
IV) was recently described in cystic fibrosis patients, affecting the chemotaxis and adhesion 
of monocytes, but not disrupting neutrophil functions. Mutations of the cystic fibrosis 
transmembrane conductance regulator (CFTR) gene seem to influence the RhoA and CDC42 
dependent activation of β1-, β2-integrins in a monocyte specific manner, contributing to the 
pathogenesis of cystic fibrosis191,192.  
When talking about impaired immune cell motility and functions, the Wiskott–Aldrich 
Syndrome (WAS) should also be mentioned, that is an X-linked complex disorder caused by 
the lack of Wiskott–Aldrich Syndrome protein (WASP) expression. WASP is a regulator of 
actin polymerisation and its expression is restricted to the hematopoietic lineage193. This 
disease is strongly linked to the defects of cytoskeletal reorganisation essential for immune 
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functions such as migration, antigen uptake and immunological synapse formation, thus 
effecting both innate and adaptive immunity194. The lack of cell polarization and impaired 
chemotaxis was observed in human monocytes195, PMNs196, macrophages197 and dendritic 
cells198 of WAS patients. As the assembly and disassembly of podosomes is a dynamic 
process mediated by fast actin reorganisation, it is not surprising, that WASP is required for 
their formation in myeloid cells199,200, and the integrins forming their adhesion rings also 
require a cytoskeletal connection201. Podosome assembly199,200,202 and the clustering of β2-
integrins166,196 are disrupted in PMNs, macrophages and dendritic cells of WAS patients and 
WASP-deficient mice202.  
CR3 was also shown to have a role in the pathogenesis of systemic lupus 
erythematosus (SLE). A single nucleotide polymorphism in the CD11b chain (rs1143679) 
is identified as a risk factor in SLE203. The rs1143679 SNP means an arginine to histidine 
change (R77H) in the CD11b molecule that was shown to cause functional changes. The 
expression of cell surface CD11b is not altered, and the receptor can undergo activation 
induced conformational changes204,205. MacPherson et al. showed reduced iC3b mediated 
phagocytosis and severely compromised adhesion to ICAM-1, ICAM-2 and iC3b in cell 
lines transfected with the mutant genes204. Rhodes et al. observed reduced iC3b mediated 
phagocytosis and adhesion in monocytes and monocyte-derived macrophages of donors 
homozygous for this mutation, moreover the TLR inhibitory function of CR3 engagement 
also seemed to be compromised205. The impairment of iC3b mediated phagocytosis was also 
confirmed by Fossati-Jimack et al. on monocytes, macrophages and neutrophils, however 
they found no alterations in neutrophil adhesion and TLR mediated cytokine release by 
monocytes and dendritic cells206. Though these results might be controversial, it is evident, 
that this mutation effects CR3 mediated functions, which can be a result of the altered 
regulation of ligand binding under shear forces for the mutant receptor207. 
These severe deficiencies are rare and hard to study, but underline the essential role of 
these adhesion related molecules. There are knock-out mice modelling these human 
syndromes, but the manifestations of these mutations are not always consistent with those 
observed in humans. Table 2. shows the main features of these deficiencies in humans, the 
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CR3 and CR4 are cell surface receptors involved in cell adherence, migration and 
phagocytosis, some of the most important functions of myeloid cells. The individual function 
of these receptors has not been studied in depth before partly due to technical difficulties. 
 
Our aims were: 
 
1. To differentiate the participation of CR3 and CR4 in: 
a) cell adherence to a fibrinogen coated surface  
b) podosome formation 
c) migration 
d) phagocytosis of iC3b opsonized Staphylococcus aureus 
 
2. To compare these functions on human neutrophil granulocytes and monocytes 
isolated from the blood of healthy donors, and in vitro differentiated monocyte 
derived macrophages and dendritic cells. 
 
3. To study these processes under both physiological and inflammatory conditions 






3. Materials and methods 
3.1. Isolation of human monocytes and neutrophil granulocytes 
Monocytes were isolated from buffy coat obtained from healthy donors and provided 
by the Hungarian National Blood Transfusion Service. Informed consent was provided for 
the use of blood samples according to the Helsinki Declaration. Peripheral blood 
mononuclear cells (PBMC) were separated by Ficoll-Paque PLUS (GE Healthcare Bio-
Science, Uppsala, Sweden) density gradient centrifugation and monocytes were isolated 
negatively by using the Miltenyi Monocyte IsolationKit II (Miltenyi Biotech, Bergisch 
Gladbach, Germany). Purity of isolated monocytes was analysed by flow cytometry using 
anti-CD14 antibody (ImmunoTools GmbH, Friesoythe, Germany).  
For the isolation of neutrophil granulocytes PBMC were removed by Ficoll-Paque 
PLUS density gradient centrifugation, then dextran sedimentation was performed using 
Dextran T-500 (Pharmacia Fine Chemicals, Uppsala, Sweden). Red blood cells were lysed 
in hypotonic buffer. Purity of isolated neutrophils was analysed by flow cytometry using 
anti-CD16 and anti-CD14 antibodies (ImmunoTools GmbH). 
 
3.2. Generation of monocyte-derived macrophages (MDMs) and monocyte-derived 
dendritic cells (MDDCs) 
To generate MDDCs and MDMs, monocytes were isolated with Miltenyi CD14 
MicroBeads from PBMC. Cells were cultivated in RPMI-1640 Medium (Sigma-Aldrich 
Inc., St Louis, MO) supplemented with gentamicin (Sigma-Aldrich) and 10% FCS (Sigma-
Aldrich). To generate MDMs 40 ng/ml rHu GM-CSF (R&D systems, Minneapolis, USA) 
was added to the isolated monocytes. To generate MDDCs 40 ng/ml rHu GM-CSF (R&D 
systems) and 15 ng/ml rHu IL-4 (R&D systems) were added to the monocytes. Cytokines 
were resupplied on day 3 of differentiation. Studies were carried out on day 5. 
 
3.3. Blocking of CD11b/CD18 and CD11c/CD18 by antibodies 
In blocking experiments the anti-CD11b (monoclonal mouse IgG1 clone TMG6-5, 
provided by István Andó at BRC Szeged, Hungary or monoclonal mIgG1 clone ICRF44, 
Biolegend, San Diego, CA, USA) or anti-CD11c antibody (monoclonal mouse IgG1 clone 
3.9, Biolegend,) was used. These antibodies are specific for the ligand binding domain of 
the corresponding integrin and were used in sterile, azide-free form at saturating 
concentration previously titrated by flow cytometry. The effect of receptor specific 
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antibodies was compared to samples incubated with an isotype matched control antibody 
(mouse IgG1 clone MOPC-21, Biolegend). To exclude Fc-receptor mediated phagocytosis 
and the binding of the blocking monoclonal antibodies we used an Fc-receptor blocking 
reagent (Miltenyi Biotech) prior to the antibody treatment. Cells were incubated with the 
receptor-specific antibodies for 30min at 4°C then used in the functional studies without 
washing, since unblocked integrins are known to recycle to the cell surface from an 
intracellular pool20, that would decrease the efficiency of receptor blocking. 
 
3.4. RNA silencing in macrophages 
RNA silencing was performed according to the method of Prechtel209. We used 
commercially available predesigned Qiagen (Germany) AllStar Negative control siRNA and 
Qiagen Genome Wide predesigned siRNA for CD11c (Hs_ITGAX_6) and CD11b 
(Hs_ITGAM_5). Cells were transfected on day 3 and day 5 of differentiation with 20μg 
siRNA to generate CD11b silenced, CD11c silenced or negative control silenced MDMs at 
day 6. The expression of CD11b and CD11c was analysed on day 6 by flow cytometry with 
anti-CD11b-FITC and anti-CD11c-APC (ImmunoTools GmbH). Subsequent experiments 
were carried out on the same day. 
 
3.5. Induction of inflammatory condition using LPS treatment 
MDMs and MDDCs were treated with 100 ng/ml bacterial lipopolysaccharide (LPS, 
Sigma-Aldrich) on the 5th day of differentiation to induce cell activation. Cells were cultured 
in 12-well cell culture plates at 106 cells/ml with LPS or without LPS (untreated control) for 
different time periods.  
 
3.6. Monitoring the expression of CD11b and CD11c during LPS induced activation 
The expression of CD11b and CD11c was measured by flow cytometry at different 
time points during the LPS induced cell activation. LPS treated and untreated control cells 
were harvested after 30 minutes, 24 hours or 48 hours, and washed with ice cold PBS 
(phosphate buffered saline solution) supplemented with 0,4% sodium azide and 1% FCS. 
Cells were labelled with anti-CD11b-FITC and anti-CD11c-APC (ImmunoTools GmbH) for 
20 minutes on ice. The expression of the receptors was compared to the appropriate untreated 
control sample at each time point. Samples were analysed on Cytoflex flow cytometer 
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(Beckman Coulter) using CytExpert software for data acquisition and Kaluza Analysis 
software for data analysis.  
 
3.7. Analysis of β2-integrin conformational state 
The conformation state of β2-integrins was determined using the activation epitope 
specific mouse monoclonal mAb24 antibody labelled with Alexa488 (BioLegend). 5x105 
cells were resuspended in 400 µl of RPMI-1640 medium and labelled with mAb24-Alexa488 
antibody for 20 minutes on ice under sterile conditions. Without washing, the tubes were 
moved to a 37°C CO2 incubator or left on ice (0-minute controls). To induce activation, 100 
ng/ml LPS was added to the cells at the beginning of the 37°C incubation. After the 
incubation time cells were washed with ice cold PBS supplemented with 0,4% sodium azide 
and 1% FCS and put on ice immediately, to stop the receptor internalization. Samples were 
analysed on Cytoflex flow cytometer at 0 minutes and 30 minutes. Confocal microscopy 
images were prepared at 0, 5 and 30 minutes by Olympus IX81 confocal microscope (60x 
objective) and FluoView500 software. 
 
3.8. Analysis of adhesion by confocal microscopy 
The wells of a CELLview cell culture dish with glass bottom (Greiner Bio-One, 
Kremsmünster, Austria) were coated with 10μg/ml fibrinogen (Merck, Darmstadt, 
Germany) in PBS for 1 hour at 37°C. After that wells were washed 2 times with PBS and 
free surfaces were blocked with synthetic copolymer poly(L-lysine)-graft-poly(ethylene 
glycol) (PLL-g-PEG, SuSoS AG, Dübendorf, Switzerland) for 30min at RT. After washing 
the wells 2 times with PBS, 5x104 cells in RPMI1640-10% FCS were immediately 
transferred to the wells and let to adhere for 30min at 37°C in a CO2 incubator. After the 
incubation samples were fixed with 2% paraformaldehyde (Sigma-Aldrich) for 10min and 
unbound cells were removed by washing 2 times with PBS. The number of adhered cells 
was determined by staining the nuclei with Draq5 (BioLegend) diluted 1:1000 (5µM) in PBS 
and incubated for 15min at RT. Samples were analysed by Olympus IX81 confocal 
microscope (10x objective) and FluoView500 software. 10 representative fields were 
scanned in each well, the number of adhered cells was determined by ImageJ software. To 
analyse the contact zone of the cells the actin cytoskeleton was stained with phalloidin-
Alexa488 (Molecular Probes, Invitrogen, Eugene, Oregon, USA). The probe was 80x diluted 
in PBS-0,1% Triton-X (Sigma-Aldrich) and cells were stained for 15min at 37°C and after 
that washed 2 times with PBS. Samples were analysed by Olympus IX81 confocal 
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microscope (60x objective) and FluoView500 software. Pictures were further analysed by 
ImageJ software. 
 
3.9. Analysis of adhesion with the computer-controlled micropipette 
Single cell adhesion force was analysed with an imaging-based automated 
micropipette (Cell-Sorter) with the collaboration of Rita Ungai-Salánki, Barbara Francz, 
Tamás Gerecsei and Bálint Szabó in the Department of Biological Physics, Eötvös Loránd 
University as described previously210,211. Briefly, Petri dishes were coated by 10μg/ml 
fibrinogen (Merck) in phosphate buffered saline solution (PBS) for 1 hour at 37°C. Dishes 
were washed 2 times with PBS and the surface was blocked with the synthetic copolymer 
poly(L-lysine)-graft-poly (ethylene glycol) (PLL-g-PEG, SuSoS AG) in order to inhibit non-
specific cell adhesion for 30 min at RT. After washing the Petri dish again with PBS, 7,5x104 
cells in RMPI-10% FCS were placed onto the coated surface. Cells were incubated for 
30minutes at 37°C in 5% CO2 atmosphere. Cultures were washed 3–4 times with Hanks’ 
Balanced Salt solution with sodium bicarbonate without phenol red buffer (HBSS, Sigma-
Aldrich) to remove floating cells. Region of interest (ROI) of the Petri dish was scanned by 
a motorized microscope (Zeiss Axio Observer A1) equipped with a digital camera 
(Qimaging Retiga 1300 cooled CCD). Cells were automatically recognized by the CellSorter 
software. To minimize the duration of the measurement, the shortest path of the micropipette 
was calculated by software212. Individual cells were visited and probed by the glass 
micropipette. The micropipette with an aperture of 70μm approached the surface to a 
distance of 10μm. Vacuum was generated in a standard syringe connected to the micropipette 
via a high speed normally closed fluid valve. To probe cell adhesion the valve was opened 
for 20ms generating a precisely controlled fluid flow and corresponding hydrodynamic 
lifting force acting only on the targeted cell. The hydrodynamic lifting force was calculated 
by running computer simulation solving the Navier-Stokes equation in a geometry 
corresponding to the experimental setup211. After each cycle of the adhesion force 
measurement the ROI of the Petri dish was scanned again, and the vacuum was increased to 
the next level. The micropipette visited again each location determined after the initial scan. 
Suction force was increased as long as most of the cells were removed. We counted the 
number of cells in the images before and after each cycle of the adhesion force measurement 
and calculated the ratio of still adhering cells of the population placed onto the surface at the 




3.10. Analysis of adhesion by EPIC BT biosensor measurement 
Adhesion kinetics were measured on the Corning EPIC biosensor in collaboration with 
Norbert Orgován and Róbert Horváth in the Institute of Technical Physics and Material 
Sciences (Nanobiosensorics “Lendület” Group) as described previously in details213. Briefly, 
each well of a standard microtiter plate contains an optical grating at its bottom which 
permits the illuminating light to be incoupled in the waveguide. Light beams in the 
waveguide interfere with each other; destructive interference precludes wave guiding, while 
constructive interference leads to resonance and to the excitation of a guided light mode. The 
latter can be achieved only at a discrete illuminating wavelength, called resonant wavelength 
(λ). The guided light mode generates an exponentially decaying evanescent field in a 100–
200nm thick layer over the sensor, which probes the local refractive index (RI) at this 
interface. Any process accompanied by RI-variations in this layer (bulk RI change, 
molecular adsorption, cell spreading, or dynamic redistribution in the cells) untunes the 
resonance by altering the phase-shift of the propagating light when it is reflected from the 
interface (leading to destructive interference at the original resonance wavelength). The 
primary output of the EPIC sensor is then the shift of the resonant wavelength, Δλ.  
Wells were coated by 10μg/ml fibrinogen (Merck) in phosphate buffered saline for 1 
hour at 37°C. After that wells were washed 3 times with PBS and free surfaces were blocked 
with synthetic copolymer poly(L-lysine)-graft-poly(ethylene glycol) (PLL-g-PEG, SuSoS 
AG) for 30min at RT. After washing 3 times with PBS, 2x104 cells in RPMI-10% FCS were 
immediately transferred to the wells and the registration of the Δλ was continuously 
monitored throughout the experiment (120 min). 
 
3.11. Analysis of the contact surface by confocal microscopy 
3.11.1. Generation of the adhesive surface and adherent cell layer 
The wells of a CELLview cell culture dish with glass bottom (Greiner Bio-One) were 
coated with 10 μg/ml fibrinogen (Merck) in phosphate buffered saline (PBS) solution for 1 
h at 37 °C, free surfaces were blocked with synthetic copolymer poly(L-lysine)-graft-
poly(ethylene glycol) (PLL-g-PEG, SuSoS AG) for 30 min at 37 °C. After washing, 104 cells 
in RPMI1640 supplemented with 10% FCS were plated onto the adhesive surface. Cells 
were let to adhere for 60 min at 37 °C in a CO2 incubator, then fixed with 2% 
paraformaldehyde for 10 min at 37 °C. Unbound cells were removed by washing two times 
with PBS.  
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3.11.2. Staining of the actin cytoskeleton and podosome counting. 
To analyse the podosome formation on the contact zone the actin cytoskeleton of 
adhered cells was stained with phalloidin-Alexa488 (Molecular Probes) diluted 1:100 in 
PBS-0,1% Triton X-100 (Reanal, Budapest, Hungary) for 15 min, then washed 2 times with 
PBS. Nuclei were stained with Draq5 (BioLegend) diluted 1:1000 (5µM) in PBS for 15 min. 
Samples were analysed by an Olympus IX81 confocal microscope (60x objective) applying 
Fluowiev500 confocal workstation. 
The number of podosomes was counted using the method described by Cervero et 
al.214. Briefly, the podosome number and contact zone area of the cells was determined using 
ImageJ software. Podosome density was calculated as the number of podosomes per 100 
µm2 cell covered area. Cells were analysed on 5 representative microscopy fields per sample.  
 
3.11.3. Staining of CD11b/CD11c on adherent cells 
Fixed samples were permeabilized with 0.1% Tween-20 (Reanal) in PBS for 20 min 
at 37 °C. The permeabilizing solution was replaced with a blocking solution: 0.2% gelatine 
(Merck) in 0.1% Tween-20 in PBS and incubated for 1 h at 37 °C. The antibodies were 
diluted in the blocking solution; primary antibodies were incubated overnight at 37 °C, then 
secondary antibodies for 2 h at 37 °C. Cells were washed with 0.1% Tween-20 in PBS 3 
times for 5 min each before adding the secondary antibody. Antibodies used for staining: 
anti-CD11b (EP1345Y, Abcam, Cambridge, UK), anti-CD11c (EP1347Y, Abcam), goat 
anti-rabbit IgG-A647 (Molecular Probes). After the secondary antibody staining cells were 
washed 3 times for 5 min each with 0.1% Tween-20 in PBS. The actin cytoskeleton was 
stained with phalloidin-Alexa488 (Molecular Probes) 1:80 diluted in 0.1% Tween-20 PBS 
for 45 min at 37 °C. Samples were analysed by an Olympus IX81 confocal microscope (60x 
objective) applying Fluowiev500 confocal workstation. 
 
3.12. Phagocytosis of Staphylococcus aureus  
To test the phagocytic capacity of immune cells Staphylococcus aureus (Wood strain 
without protein A) BioParticles (Molecular Probes) conjugated with Alexa488 or pHrodo 
Green was used. S. aureus was opsonized with normal human serum for 1 h at 37 °C, then 
washed extensively and offered to the cells under different conditions. During opsonization, 
S. aureus activates the alternative pathway of the complement system, and iC3b, the main 
ligand of CR3 and CR4, is deposited on its surface215,216. All reagents were diluted in Hank’s 
Balanced Salt Solution (HBSS) buffer supplemented with 5% FCS and 5mM glutamine, pH 
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7.4. The cells were incubated with the blocking antibodies for 30 min on ice before the 
phagocytosis. Without a washing step S.aureus was offered to them at 200 μg/ml 
concentration for 90 min at 37 °C in a CO2 incubator or on ice. 100 μl of bacteria suspension 
diluted to 400 μg/ml (containing 1.2×107 S. aureus particles) were added to 100 μl volume 
of cell suspension (5×105 cells), resulting in a 200 μg/ml final concentration. The ratio of 
cells to bacteria was 1:24. After 90 min, phagocytosis was stopped by washing the samples 
with ice cold PBS and placing the cells on ice. Samples were analysed immediately by flow 
cytometry using BD FACS Calibur flow cytometer and CellQuest software for data 
acquisition and FCS Express 3.0 software for data analysis. 
 
3.13. Analysis of transmigration 
Cell migration was analysed using 24 well Transwell plates (polycarbonate membrane 
with 5 µm pore, Corning, Corning, NY, USA). 105 cells in 100 µl RPMI-1640 medium was 
plated in the upper chamber, and the lower chamber was filled with 600 µl of 
chemoattractant or medium (negative control). For the untreated cells 62.5 nM N-
Formylmethionine-leucyl-phenylalanine (fMLP, Sigma-Aldrich) was used as a 
chemoattractant and the migration was stopped after 1 hour. For the LPS treated cells we 
used 200 ng/ml CCL19 (BioLegend), and the migration was stopped after 2 hours for 
MDDCs and 4 hours for MDMs. At the end of the incubation time, EDTA was pipetted to 
the lower chamber without removing the membrane at a final concentration of 12.5 mM. 
After 5 minutes at 37°C cells were resuspended from the lower chamber and the bottom of 
the membrane, placed on ice and measured immediately. The number of transmigrated cells 
was measured in a volume of 250 µl/sample by flow cytometry (Cytoflex, BC).  
 
3.14. Statistics 





4. Results I. The function of CR3 and CR4 under physiological 
conditions 
A similar role is often assumed for CR3 and CR4, since they have an overlapping 
ligand binding specificity and high sequence homology in their extracellular domains4. In 
humans they are simultaneously expressed in all myeloid cells, whereas in mice CR4 is 
expressed constitutively only on DCs. The different expression pattern in mouse and human 
cells suggests a separation of functions. Their importance in host defence is underlined by 
pathological conditions affecting the function of these receptors, like leukocyte adhesion 
deficiency, that is characterized by serious and recurrent infections. 
Our group set out to thoroughly investigate the individual role of CR3 and CR4 in 
human myeloid cells. The most studied functions of these receptors are cell adhesion, 
migration and phagocytosis. First, we studied their participation in these processes during 
physiological conditions, with myeloid cells isolated from the blood of healthy donors.  
 
4.1. Adhesion to fibrinogen coated surfaces 
We set out to study the participation of CR3 and CR4 in the adhesion of human 
monocytes, monocyte derived macrophages (MDMs) and dendritic cells (MDDCs). We used 
fibrinogen coating for the adhesion assay, because it is a specific ligand for CR3 and CR4 
on these cells.  The adhesive capacity of cells was assessed by fundamentally different 
approaches: a widely used classical adhesion assay and two state-of-the-art biophysical 
methods. The classical method consists of counting the number of cells attached to the 
fibrinogen coated surface, whereas with the biophysical methods we gain information about 
the quality of adherence. The computer controlled micropipette is capable of measuring the 
strength of adhesion and the optical waveguide biosensor records adhesion kinetics. The 
biophysical measurements were carried out with the help of our collaboration partners at the 
Institute of Technical Physics and Material Sciences (Róbert Horváth, Nanobiosensorics 
“Lendület” Group) and at the Department of Biological Physics, Eötvös Loránd University 
(Bálint Szabó). 
 
4.1.1. The classical assay: CR4 dominates adhesion over CR3 
To study the individual role of CR3 and CR4 we used ligand binding site specific 
monoclonal antibodies prior to the cell attachment. To exclude the Fc-receptor mediated 
binding of antibodies an Fc-receptor blocking reagent was used, and the effect of receptor 
specific antibodies was compared to samples incubated with an isotype matched control 
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antibody. In the classical adhesion assay the effect of receptor specific treatment was 
quantified as the number of adherent cells on the fibrinogen coated surface, data are shown 
as the percent of adherent cells compared to the isotype treated control. As shown in 
Figure 6. the blocking of CD11c significantly decreased the number of adherent cells in the 
case of monocytes and MDDCs, and slightly, but not significantly blocked the adherence of 
MDMs too. Blocking CD11b had no effect on the number of adhered cells in the case of 
MDMs and MDDCs, but it was slightly reduced for monocytes.  
 
 
Figure 6. Number of adherent cells after blocking CD11b or CD11c with antibodies. 
Monocytes (A), MDMs (B) and MDDCs (C) were treated with ligand binding site specific 
monoclonal anti-CD11b or anti-CD11c or isotype control antibodies prior to the adhesion 
assay. Cells were let to adhere on a fibrinogen coated surface and unbound cells were 
washed away. Nuclei were stained with Draq5 DNA dye and counted with ImageJ software. 
The number of adhered cells was normalized to the isotype control antibody treated samples, 
shown as 100%. Results of 3 donors are shown as mean ± SD. One-way ANOVA with Tukey’s 
post-test was used to determine significant differences compared to control, *=p < 0.05. 
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Myeloid cells are known to spread on two-dimensional surfaces, creating a large 
contact area with the substrate. Since this process is regulated by integrin-ligand interactions 
and actin polymerization, we assessed the quality of adhesion by measuring the area of this 
contact surface. The actin filaments were stained with a phalloidin-Alexa488 probe and 420 
nm optical sections of the contact zone were analysed by confocal microscopy. The blocking 
of CD11b resulted in a bigger contact area for MDMs (Fig. 7E) and a more polarized and 
slightly larger surface for MDDCs (Fig. 7H) and monocytes 
(Fig. 7B). In contrast, the blocking of CD11c decreased the size of the contact area for 
MDMs (Fig. 7F) drastically, but it did not affect the size of MDDCs (Fig. 7I) and monocytes 
(Fig. 7C).  
To quantify these changes we measured the area of the contact zone based on the actin 
staining using ImageJ software. As shown in Figure 8 we established 3 size categories for 
the larger MDMs (Fig. 8A) and MDDCs (Fig. 8B) and 2 for the smaller monocytes (Fig. 8C) 
and determined their proportion in the population of adherent cells (Fig. 9). The calculated 
area data was consistent with the changes observed on the confocal microscopy pictures. 
Blocking CD11b with antibodies shifted the population towards cells with a large contact 
area on all three cell types and minimised the number of smaller area cells, showing that 
CD11b acts against spreading (Fig. 9). The blocking of CD11c decreased the spreading area 
of MDMs (Fig. 9B), resulting in the majority of small area cells, but it did not affect the area 






Figure 7. The contact area of adherent cells after blocking CD11b or CD11c with 
antibodies. Monocytes (A-C), MDMs (D-F) and MDDCs (G-I) were treated with anti-
CD11b (B,E,H), anti-CD11c (C,F,I) or isotype control (A,D,G) antibody, then plated on a 
fibrinogen coated surface. The actin cytoskeleton was stained with phalloidin-Alexa488 
(shown in green), and nuclei were visualized with Draq5 DNA dye (in red). Confocal 





Figure 8. The contact area size categories of adherent cells. Adherent cells were divided 
into categories based on the size of their contact zones. MDMs (A) and MDDCs (B) were 
categorised into the following three groups: small (smaller than 800 µm2), medium (between 
800–1600 µm2), large (bigger than 1600 µm2). For monocytes (C) the categories were small 






Figure 9. The distribution of contact zone size categories after blocking CD11b or CD11c 
with antibodies. Adherent cells were divided into categories based on the size of their 
contact zones. MDMs (B) and MDDCs (C) were categorised into the following three groups: 
small (smaller than 800 µm2), medium (between 800–1600 µm2), large (bigger than 1600 
µm2). For monocytes (A) the categories were small (smaller than 400 µm2) and large (bigger 
than 400 µm2). The contact area was measured for 200 cells/sample, one representative is 




4.1.2. The computer controlled micropipette method: CR4 is important for a strong cell 
attachment 
Cell adhesion to fibrinogen was also evaluated using the state-of-the-art biophysical 
method, namely the force of cell attachment was measured with a computer-controlled 
micropipette. Cells were let to adhere on a fibrinogen coated surface, and their adhesion 
force was assessed by trying to pick them up with the micropipette using vacuum induced 
fluid flow. The pick-up process was repeated several times with increased vacuum, and cells 
remaining on the surface were counted after each cycle. Applied vacuum was converted to 
force (µN) based on computer simulations. Cells were treated with ligand binding site 
specific or an isotype control antibody prior to adhesion, and data are presented as the percent 
of adhered cells compared to the control samples. In the case of monocytes (Fig. 10A), the 
force of adhesion decreased with both anti-CD11b and anti-CD11c treatment, that was also 
observed previously with the classical assay (Fig. 6A). For MDMs and MDDCs the blocking 
of CD11c decreased the strength of attachment, whereas blocking CD11b increased it (Fig. 
10B-C). This opposing effect of the two receptors was also seen in our previous confocal 





Figure 10. The force of cell adhesion after blocking CD11b or CD11c with antibodies. The 
force of adhesion was measured using a computer controlled micropipette by trying to pick 
cells up using vacuum induced fluid flow. This process was repeated several times with 
increasing amount of vacuum and the number of remaining cells was counted. Applied 
vacuum was converted to force (µN) based on computer simulations. Monocytes (A), MDMs 
(B), and MDDCs (C) were treated with monoclonal anti-CD11b or anti-CD11c antibodies 
prior to adhesion, and data are presented as the percent of adhered cells compared to the 
isotype control samples. Data presented are mean ± SD of three independent donors’ 
samples. Two-way ANOVA with Bonferroni post-test was used to determine significant 




4.1.3. Analysis of adhesion kinetics using the optical waveguide biosensor: CR4 
dominates adhesion over CR3 
The second biophysical method we used to study the kinetics of adhesion was the EPIC 
label free optical waveguide biosensor. This method enables the real-time monitoring of a 
100–200 nm width layer over the adhesive surface by analysing the refractive index 
alterations, detected as the shift of resonant wavelength (Δλ). This volume is only accessible 
for actively adhering and spread-out cells, thereby non adherent cells are excluded from the 
measurement. The wavelength shift is proportional with the coverage of the sensor, meaning 
that we detect a combined signal of the number of the adhered cells and the size and density 
of their contact area213,217.  
Since this is a very sensitive label free method, instead of antibodies we used RNA 
silencing to study the participation of CR3 and CR4. We used MDMs, where the expression 
of CD11b or CD11c was downregulated using siRNA. For control, cells were transfected 
with negative control siRNA. The cell surface expression of CR3 and CR4 was verified 
using flow cytometry (Fig. 11A-B). To validate our data obtained from siRNA treated cells, 
we measured the force of adhesion with the micropipette as we have done previously (Fig. 
11C). The siRNA silencing resulted in similar changes in the adhesive capacity of MDMs 
as the receptor blocking with antibodies, confirming the efficiency of this method. 
One representative graph of the adhesion kinetics of CD11b or CD11c silenced MDMs 
is shown on Figure 12A. The downregulation of CD11b resulted in a higher wavelength 
shift, whereas the silencing of CD11c decreased the detected signal in comparison to the 
control siRNA treated cells. To compare this with the previous measurements we determined 
the Δλ value at the timepoint (30 minutes) we used for the classical and micropipette 
adhesion assays (Fig. 12B). The adhesive capacity of CD11c siRNA treated MDMs 
significantly decreased at 30 minutes of adhesion, while it was slightly elevated in the case 





Figure 11. The downregulation of CD11b and CD11c expression with siRNA silencing 
MDMs were differentiated under conditions where CD11b or CD11c expression was 
downregulated by receptor specific siRNA. Control cells were treated with negative control 
siRNA. The expression of CD11b (A) and CD11c (B) was analysed by flow cytometry prior 
to the functional assays. Data of 4 experiments are presented as the percent of cell surface 
expression compared to the control siRNA treated samples (mean ± SD). One-way ANOVA 
with Tukey’s post-test was used to determine significant differences compared to control, 
**=p < 0.01. (C) To validate this method the force of adhesion was measured with the 
micropipette. Data of 3 experiments are presented as the percent of adhered cells compared 
to the control siRNA treated samples (mean ± SD). Two-way ANOVA with Bonferroni post-







Figure 12. Adhesion of RNA silenced macrophages. (A) Kinetic curves of adhering MDMs 
was recorded by EPIC optical biosensor. The shift in detected wavelength (Δλ) is plotted 
against time in the case of CD11b (dashed line), CD11c (dotted line) or negative control 
(black line) siRNA silenced cells. The shaded area around each line shows the deviation 
between the parallel samples. One representative measurement out of three is shown. (B) 
The wavelength shift values (Δλ) were determined at 30 minutes of adhesion, data are shown 
as mean ± SD of three independent measurements. Paired t-test was used to determine 
significant differences compared to control siRNA treated samples, *=p<0.05. 
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4.2. Migration  
4.2.1. Both CR3 and CR4 participate in the migration of MDMs and MDDCs 
MDMs and immature MDDCs are known to migrate towards N-formylated peptides 
as they express formyl peptide receptors (FPRs). As a synthetic ligand N-Formylmethionyl-
leucyl-phenylalanine (fMLP) was used, which acts similarly on FPRs as the natural ligands. 
The migration capacity of MDMs and MDDCs was tested using a transwell assay with a 5 
µm pore size polycarbonate membrane. To study the involvement of CD11b and CD11c, 
ligand binding site specific antibodies were employed, and the number of transmigrated cells 
were counted by flow cytometry. As shown in (Fig. 13) both anti-CD11b and anti-CD11c 
reduced the number of cells able to migrate through the membrane. For MDMs the blocking 
of CR3 resulted in a significantly stronger inhibition than the blocking of CR4, while in the 
case of MDDCs the extent of inhibition was the same for both receptors.  
 
 
Figure 13. Analysis of migration on MDMs and MDDCs using fMLP as a 
chemoattractant. MDMs (A) and MDDCs (B) were treated with either anti-CD11b or anti-
CD11c ligand binding site specific antibodies before migration, and the number of 
transmigrated cells were counted by flow cytometry after detachment using EDTA. The 
number of migrated cells was normalized to the isotype control antibody treated samples, 
shown as 100%. Results of 4 donors are shown as mean ± SD. One-way ANOVA with Tukey’s 
post-test was used to determine significant differences compared to control, *=p < 0.05; 




4.3. Adhesive structures of human phagocytes – podosomes 
Podosomes are adhesive structures known to mediate short-lived adhesion spots that 
are formed and quickly remodelled during migration. Considering their importance in cell 
attachment and movement, we set out to study their formation and patterns on various cell 
types.  
 
4.3.1. Podosome patterns 
Podosomes can be examined by confocal microscopy after staining the actin 
cytoskeleton with phalloidin-Alexa488 (Fig. 14). The actin core of these structures appears 
as a small, strongly fluorescent dot on the contact surface of cells. We found characteristic 
podosome patterns in the case of various human phagocytes. Smaller monocytes 
(Fig. 14A) displayed an even distribution across the substrate contacting surface. The 
podosomes of MDMs (Fig. 14B) showed either a similar distribution, or a belt like pattern. 
In MDDCs however (Fig. 14C) podosomes are arranged in clusters or accumulate in the 
leading edge of polarized cells. Neutrophil granulocytes (Fig. 14D) also have an even 
distribution of actin cores. 
 
4.3.2. Localization of CD11b and CD11c on the contact surface of adherent cells 
The actin core of podosomes is surrounded by cytoskeleton associated proteins and 
adhesion molecules, such as integrins. The importance of β2-integrins in podosome 
formation and podosome mediated adhesion has been proven, but the individual role of these 
receptors had not been investigated so far. We studied the localization of CD11b and CD11c 
in the contact zone of MDMs and MDDCs adhered to a fibrinogen coated surface. The 
podosome actin cores were visualized using phalloidin-Alexa488 staining 
(Fig. 15A,D,G,J). Confocal microscopy analysis revealed the presence of both CD11b (Fig. 
15C,I) and CD11c (Fig. 15F,L) in the podosome adhesion ring on the contact surface of both 
cell types. The immunocytochemical staining of CD11b and CD11c showed a wider 
localization than actin (Fig. 15B,E,H,K), which is in correspondence with data showing an 






Figure 14. Podosome patterns of human phagocytes attached to fibrinogen. Different 
podosome formation can be observed in the case of human monocytes (A), MDMs (B), 
MDDCs (C) and neutrophil granulocytes (D). Cells were let to adhere for 30 minutes on a 
fibrinogen coated surface, fixed with paraformaldehyde and unbound cells were washed 
away. The actin cytoskeleton was stained with phalloidin-Alexa488 (shown in green), nuclei 
were stained with Draq5 (shown in red). Representative confocal microscopy images were 





Figure 15.  Localization of CD11b and CD11c on the contact surface of human myeloid 
cells. MDMs (A-F) and MDDCs (G-L) were plated to a fibrinogen coated surface, followed 
by staining with phalloidin-Alexa488 (A,D,G,J), anti-CD11b (B,H) or anti-CD11c (E,K). 
Merged images are shown in C,F,I,L. CD11b and CD11c are located around the actin core 
of podosomes in both cell types. Confocal microscopy images of one representative 
experiment out of 3 are shown.  
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4.4. Phagocytosis of iC3b opsonized Staphylococcus aureus 
One of the most studied functions of CR3 and CR4 are the phagocytosis of 
complement opsonized microbes. As a model for our experiments we used Staphylococcus 
aureus, an opportunistic pathogen, that is able to inflict skin or respiratory infections219. S. 
aureus activates the alternative pathway of the complement system, and iC3b, the main 
ligand of CR3 and CR4, is deposited on its surface215,216. 
 
4.4.1. Comparing differently labelled S. aureus particles  
The phagocytic capacity of monocytes, MDMs, MDDCs and neutrophils was 
measured using iC3b opsonized Staphylococcus aureus conjugated with Alexa488 or 
pHrodo Green dye. Using bacteria labelled with Alexa488 both surface bound and 
internalized particles can be detected, while employing the pH sensitive pHrodo Green dye, 
bacteria are only visible when they reach the acidic milieu of phagolysosomes on the 
degradative pathway. Representative histograms demonstrating the differences in the 
detection of bacteria populations are shown in Figure 16 for MDMs (Fig. 16A,B) and 
MDDCs (Fig. 16C,D). The most prominent difference between the two dyes is revealed 
when cells are kept on ice (Fig. 16A-D dashed histograms), when the internalization of 
surface bound particles can not take place. Under these circumstances bacteria labelled with 
Alexa488 will be detected by flow cytometry although they are only bound on the cell 
surface. Using this method of labelling the amount of surface bound and internalized bacteria 
can not be distinguished under physiological conditions, where cells are kept at 37ºC in CO2 
incubator during phagocytosis (Fig. 16A,C, solid black histograms). The discrimination of 
phagocytosed bacteria destined for degradation is only possible with the pH sensitive 
pHrodo Green dye, where surface bound particles are not detected (Fig. 16B,D). We will 
refer to these bacteria populations according to the method of their detection: “bound and 
internalized” for Alexa488 and “digested” for pHrodo Green labelled S. aureus.  
Comparing the activity of MDMs and MDDCs we found a significant difference in 
the amount of phagocytosed bacteria measured by Alexa488 (Fig. 16E) and pHrodo Green 
(Fig. 16F) conjugated S. aureus. The lower phagocytic capacity of MDDCs is in agreement 





Figure 16. Fluorescence intensity of bound/internalized and digested bacteria by MDMs 
and MDDCs. Panel A, C and E: results obtained employing S. aureus conjugated with 
Alexa488; panel B, D and F: results obtained with S. aureus conjugated with pHrodo Green 
dye. Representative histograms were chosen of MDMs (6 (A) and 4 (B) independent 
experiments) and MDDCs (3 (C) and 6 (D) independent experiments). Histograms: grey 
background: autofluorescence; dashed line: cells were kept on ice; black line: cells were 
kept at 37ºC in CO2 incubator during phagocytosis. Graphs E and F show the geometric 
mean fluorescence intensity of bound/internalized and digested S. aureus by MDMs and 
MDDCs, respectively. Mean ± SD of 3 independent experiments are shown. Unpaired t-test 




4.4.2.  The role of CR3 and CR4 in the phagocytosis of iC3b opsonized Staphylococcus 
aureus  
To determine the participation of CR3 and CR4 in the uptake of opsonized particles, 
cells were treated with ligand binding site specific blocking antibodies before and during the 
incubation with the bacteria. The phagocytosis assay was carried out using iC3b opsonized 
S. aureus. In the presence of the CD11b specific antibody monocytes and MDMs showed 
decreased phagocytosis when employing Alexa488 or PHrodo Green labelled bacteria (Fig. 
17). However, when macrophages were treated with the CD11c specific antibody, a 
significant reduction in the binding of Alexa488 conjugated S. aureus (Fig. 17C) could be 
observed. This blocking effect however was not present when pHrodo Green S. aureus was 
used (Fig. 17D). These findings demonstrate that CD11c participates in the binding of iC3b 
opsonized S. aureus, while further steps leading to the digestion of the coccus are mediated 
by CD11b in macrophages.  
Blocking of CR3 on MDDCs inhibited the phagocytosis of both Alexa488 (Fig. 
18A) and pHrodo Green (Fig. 18B) conjugated bacteria, whereas inhibiting CD11c had no 
effect. Experiments with neutrophil granulocytes (Fig. 18C-D) showed similar results, 





Figure 17. Phagocytic capacity of monocytes and MDMs after blocking CD11b or CD11c 
with ligand-binding site specific antibodies. Using bacteria labelled with Alexa488 (A and 
C) both surface bound and internalized particles are detected. With the pH sensitive pHrodo 
Green dye (B and D) bacteria are only visible when they reach the acidic phagolysosomes. 
The amount of bound/internalized, vs. digested fluorescently labelled bacteria was measured 
by flow cytometry. The effect of antibody treatment was compared to isotype control samples, 
shown as 100%. For monocytes (A and B) results of 4 donors are shown, mean ± SD, for 
MDMs (C and D) 6 (C) and 4 (D) donors’ results (mean ± SD) are shown. One way ANOVA 
with Tukey’s post-test was used to determine significant differences compared to control, * 





Figure 18. Phagocytic capacity of MDDCs and neutrophil granulocytes after blocking 
CD11b or CD11c with ligand-binding site specific antibodies. Using bacteria labelled with 
Alexa488 (A and C) both surface bound and internalized particles are detected. With the pH 
sensitive pHrodo Green dye (B and D) bacteria are only visible when they reach the acidic 
phagolysosomes. The amount of bound/internalized vs. digested fluorescently labelled 
bacteria was measured by flow cytometry. The effect of antibody treatment was compared 
to isotype control samples, shown as 100%. For MDDCs (A and B) results of 3 (A) and 6 
(B) independent donors (mean ± SD) are shown, for neutrophil granulocytes (C and D)  14 
(C) and 4 (D) independent donors’ results (mean ± SD) are shown. One way ANOVA with 





5. Results II. The function of CR3 and CR4 under inflammatory 
conditions 
The initial phase of an immune response after tissue injury or infection is the 
recruitment of immune cells and the establishment of an inflammatory environment. The 
subsequent activation of leukocytes alters their functions and the expression of receptors, 
costimulatory molecules and cytokines. Additionally, many pathological conditions induce 
chronic inflammation, where the continuous activation of leukocytes contributes to tissue 
damage. β2-integrins are known to play a critical role in the resolution of infections6. An 
elevated expression of CR3 or CR4 was shown on blood monocytes of rheumatoid arthritis 
patients220 and during hypertriglyceridemic conditions221, contributing to enhanced 
adhesiveness in both cases. Thus we set out to study the function of CR3 and CR4 on 
macrophages and dendritic cells under inflammatory conditions, where the activating 




5.1. Receptor expression, activation status and recycling 
5.1.1. Under inflammatory conditions the expression of CR3 and CR4 is regulated 
differently on MDMs and MDDCs  
The expression of CR3 and CR4 was monitored by flow cytometry at different time 
points during the LPS induced cell activation. Comparing the amount of CR3 and CR4 on 
the cell surface we found that LPS treatment alters their expression differently on MDMs 
and MDDCs (Fig. 19). Whereas on MDMs the expression of both CR3 and CR4 decreases, 
on MDDCs only the expression of CR3 is diminished, CR4 appears at a significantly 
elevated level.  
 
 
Figure 19. Changes in the expression of CR3 and CR4 after LPS induced activation. The 
surface expression of CR3 and CR4 was measured at different time points by flow cytometry. 
The effect of LPS treatment was compared to the appropriate untreated control sample at 
each time point, shown as 100%. For MDMs (A) results of 3 donors (mean ± SD), for 
MDDCs (B) 4 donors’ results (mean ± SD) are shown. Two-way ANOVA with Bonferroni 
post-test was used to determine significant differences compared to control, *=p < 0.05; 




5.1.2. LPS treatment enhances β2-integrin cycling in both MDMs and MDDCs 
The ligand binding affinity of β2-integrins is regulated by activation dependent 
conformational changes, when these receptors switch between an inactive bent and an 
activated extended structure. The conformational state of the receptors can be checked using 
the mouse monoclonal mAb24 antibody, which is specific for an activation epitope in the I-
like domain of the β2 chain (CD18). This determinant is revealed only in the high affinity 
receptor with an open conformation, therefore this antibody does not bind to the receptors 
of cells kept on ice (Fig. 20 and Fig. 21). Cells were incubated with the Alexa488 labelled 
mAb24 antibody for 20 minutes on ice, then, without washing, cells were moved to a 37°C 
incubator. Under the experimental conditions that were used for our functional studies, the 
receptors were in an active, open conformation, confirmed by the binding of the mAb24 
antibody.  
Confocal microscopy images showed an even distribution of β2-integrins in the cell 
membrane after 5 minutes of incubation at 37°C, whereas after 30 minutes the labelled 
receptors accumulated inside the cell (Fig. 20). Integrins are known to have a fast turnover 
between the cell surface and intracellular pools, leading to the appearance of unlabelled 
receptors on the cell surface, that bind the mAb24 antibody, increasing the fluorescence 
intensity with time. When 100 ng/ml LPS was added to the cells during the 37°C incubation 
time, the mean fluorescence intensity (MFI) was significantly higher, thus LPS enhances the 





Figure 20. Analysis of β2-integrin conformational state by confocal microscopy. 
Unstimulated cells were incubated with the Alexa488 labelled mAb24 antibody for 20 
minutes on ice, then, without washing, cells were moved to 37°C for 5 or 30 minutes or kept 
on ice (0 minutes). The receptor staining showed an even distribution in the cell membrane 
after 5 minutes of incubation on 37°C, whereas after 30 minutes the labelled receptors were 
also accumulating in the cytoplasm of the cell. Representative confocal microscopy images 





Figure 21.  Analysis of β2-integrin conformational state by flow cytometry. Cells were 
incubated with the Alexa488 labelled mAb24 antibody for 20 minutes on ice, then, without 
washing, cells were moved to a 37°C incubator for 30 minutes or kept on ice, with or without 
100 ng/ml LPS. The receptors were in an active, open conformation, confirmed by the 
binding of the mAb24 antibody, and LPS enhanced the activation and turnover of β2-
integrins. Mean fluorescence intensity (MFI) data are presented, for MDMs (A) results of 4 
donors (mean ± SD) and for MDDCs (B) 5 donors’ results (mean ± SD) are shown. Two-
way ANOVA with Bonferroni post-test was used to determine significant differences, *=p < 




5.2. Adhesion to fibrinogen coated surfaces 
5.2.1. Under inflammatory conditions both CR3 and CR4 participate in the adhesion to 
fibrinogen  
We set out to study the participation of CR3 and CR4 in the adhesion of MDMs and 
MDDCs to a fibrinogen coated surface first by a classical method, where the number of 
adherent cells on a fibrinogen coated surface was counted. To distinguish the function of 
CR3 and CR4 in adhesion under inflammatory conditions, cells were treated with either anti-
CD11b or anti-CD11c antibody prior to the assay. Unbound cells were washed away before 
counting. We found that in the case of LPS treated MDMs and MDDCs both CR3 and CR4 
participated in cell adhesion, as blocking antibodies equally decreased the number of 
adherent cells compared to the isotype control antibody treated samples 




Figure 22. The effect of anti-CD11b and anti-CD11c antibodies on the number of adhered 
cells. The antibody treated MDMs (A) and MDDCs (B) were let to adhere on a fibrinogen 
coated surface and after fixation the unbound cells were washed away. Nuclei were stained 
with Draq5 and the adherent cells were counted. The number of adhered cells was 
normalized to the isotype control antibody treated samples, shown as 100%. Results of 7 
donors are shown as mean ± SD. One-way ANOVA with Tukey’s post-test was used to 




5.2.2. LPS induced cell maturation decreases the force of adhesion significantly in 
MDDCs 
In this set of experiments we evaluated cell adhesion to fibrinogen using a state-of-
the-art biophysical method, which allows the measurement of the force of cell attachment 
with a computer-controlled micropipette. Cells were let to adhere on a fibrinogen coated 
surface, and their adhesion force was assessed by trying to pick them up with the 
micropipette using vacuum induced fluid flow. The pick-up process was repeated several 
times with increased vacuum, and cells remaining on the surface were counted after each 
cycle. Applied vacuum was converted to force (nN) based on computer simulations. 
Employing the micropipette, we observed a significantly reduced adhesion force for LPS 
treated MDDCs. In the case of LPS activated MDMs we observed only a slight decrease in 




Figure 23. Changes in the force of adhesion during LPS induced maturation. The force 
of cell attachment was measured with a computer-controlled micropipette using vacuum 
induced fluid flow. Applied vacuum was converted to force (nN). The percent of adhered 
cells was calculated by dividing the number of cells remaining on the surface after applying 
a given vacuum, by the number of cells originally contained in the population. For MDMs 
(A) and MDDCs (B) results of 3 donors are shown (mean ± SD). Two-way ANOVA with 
Bonferroni post-test was used to determine significant differences compared to control, *=p 




5.2.3. CR4 is prominently involved in the strong attachment of MDMs and MDDCs to 
fibrinogen 
To differentiate the role of CR3 and CR4 in the adhesion to fibrinogen we blocked 
either CD11b or CD11c by ligand binding site specific monoclonal antibodies. Experimental 
data are presented as the ratio of blocking antibody treated adherent cells compared to the 
isotype control treated cells. Previously we proved, that under physiological conditions the 
blocking of CD11c decreased the adhesion force of MDMs and MDDCs, CD11b did not 
play a role in cell attachment. Here we demonstrate, that during inflammatory conditions, 
both receptors become involved in adherence, however the blocking of CD11c resulted in a 




Figure 24. Changes in the force of adhesion after blocking CD11b or CD11c with 
antibodies. LPS activated cells were treated with anti-CD11b (shown in white) or anti-
CD11c (shown in black) blocking antibody before cell adhesion. The force of cell attachment 
was measured with a computer-controlled micropipette using vacuum induced fluid flow. 
Applied vacuum was converted to force (nN). Data are presented as the percent of adhered 
cells staying attached to the fibrinogen coated surface normalized to isotype control 
antibody treated samples (shown as 100%, represented by the dashed line). For MDMs (A) 
results of 3 donors (mean ± SD), for MDDCs (B) 4 donors’ results (mean ± SD) are shown. 
Two-way ANOVA with Bonferroni post-test was used to determine significant differences 




5.3.1. Under inflammatory conditions both CR3 and CR4 participate in the migration of 
MDMs and MDDCs 
Dendritic cells are known for their capacity to migrate into the lymph nodes for antigen 
presentation, and during this journey they go through a maturation process151. Maturation 
induces changes in chemokine receptor expression222, including CCR7, which is expressed 
on the cell surface 3 hours after the inflammatory stimuli223. Recent studies have shown, that 
M1 macrophages – i.e. cells activated by LPS and IFNγ – also express CCR7 and migrate in 
the direction of a CCL19 and CCL21 chemokine gradient224, which results in their 
accumulation at inflammatory sites225,226.  
The migration capacity of MDMs and MDDCs was studied using a transwell assay 
and CCL19 as a chemoattractant. Results obtained from these experiments using LPS treated 
cells shows that both CR3 and CR4 participate in migration (Fig. 25C-D). This figure also 
shows that blocking with anti-CD11b results in a slightly stronger inhibition, when compared 
to the effect of anti-CD11c, particularly in the case of unstimulated MDMs.  
 
 
Figure 25. Analysis of migration on MDMs and MDDCs using CCL19 as a 
chemoattractant. Activated MDMs (A) and mature MDDCs (B) were treated with either 
anti-CD11b or anti-CD11c ligand binding site specific antibodies before migration, and the 
number of transmigrated cells were counted by flow cytometry after detachment using 
EDTA. The number of migrated cells was normalized to the isotype control antibody treated 
samples, shown as 100%. Results of 4 donors are shown as mean ± SD. One-way ANOVA 
with Tukey’s post-test was used to determine significant differences compared to control, 




5.4. Adhesive structures of human phagocytes – podosomes 
LPS activation induces the maturation of dendritic cells, that involves changes in the 
expression profile of many proteins and the reorganization of the actin cytoskeleton. These 
changes can affect their ability for podosome formation and migration. Our aim was to 
compare the podosome formation and the localization of CD11b and CD11c on the contact 
surface of MDMs and MDDCs under LPS induced inflammatory conditions. 
 
5.4.1. MDDCs lose their podosomes during LPS induced maturation 
Cells were let to adhere on a fibrinogen coated surface, the actin cytoskeleton and 
nuclei were stained with phalloidin-Alexa488 and Draq5. As it is demonstrated in Figure 26, 
LPS treatment induced the loss of podosomes in dendritic cells (Fig. 26C-D)., whereas 
activated macrophages preserve these structures (Fig. 26A-B). To quantify these differences, 
the number of podosomes was counted based on the phalloidin staining of podosome actin 
cores using ImageJ software (Fig. 26E). These data confirmed, that the number of 
podosomes is unchanged in MDMs, but drastically decreased in MDDCs after LPS 
treatment. This remarkable difference in the ability of podosome formation explains the 
greater reduction in adhesion force of MDDCs compared to MDMs after LPS treatment. 
Previously we demonstrated that podosomes can be arranged in various patterns in different 
cell types. In the case of MDMs we observed a belt-like or even distribution, whereas in 
MDDCs clusters of podosomes appeared. Here we show, that in addition to a difference in 
podosome arrangement, the number of these structures is significantly lower for MDDCs 
than MDMs (Fig. 26E).  
 
5.4.2. Localization of CD11b and CD11c on the contact surface of adherent cells under 
inflammatory conditions 
Previously we demonstrated the presence of both CD11b and CD11c in the podosome 
adhesion ring on the contact surface of MDMs and MDDCs during physiological conditions. 
Under inflammatory conditions or upon maturation, parallel with the changes in the 
functions of various cells, podosomes might be lost. In our confocal microscopy study we 
found that LPS activated MDMs retain their ability to form podosomes with CD11b and 
CD11c around the actin core (Fig. 27.A-F). In LPS treated mature MDDCs however, with 
the loss of podosomes, CD11b and CD11c is concentrated in the cell body around the 




Figure 26. Changes in the arrangement of podosomes in the contact surface of adherent 
cells upon LPS treatment. The actin cytoskeleton of adherent cells was stained with 
phalloidin-Alexa488 (shown in green), nuclei were stained with Draq5 DNA dye (shown in 
red). Both untreated (A) and LPS treated (B) MDMs form podosomes during adhesion, 
whereas only untreated, immature MDDCs (C) have podosomes, LPS treated mature 
MDDCs (D) lose their ability for podosome formation. (E) The number of podosomes and 
cell area were counted with ImageJ software, data are shown as podosome density (number 
of podosomes per 100µm2 of cell covered area). One-way ANOVA with Tukey’s post-test 
was used to determine significant differences compared to control, *=p < 0.05, ***=p < 
0.001. Representative confocal microscopy images (A-D) and podosome density data (E) 





Fig. 27. Localization of CD11b and CD11c on the contact surface changes upon LPS 
treatment. MDMs (A–F) and MDDCs (G–L) were plated on a fibrinogen coated surface, 
followed by staining with phalloidin-Alexa488 (A,D,G,J), anti-CD11b (B,H) or anti-CD11c 
(E,K). Merged images are shown in C,F,I,L. CD11b and CD11c are located around the actin 
core of podosomes in LPS treated MDMs. In the case of LPS treated mature MDDCs, with 
the loss of podosomes, CD11b and CD11c is concentrated in the cell body around the 
nucleus, and in membrane ruffles on the leading edge. Confocal microscopy images of one 




The complement receptors CR3 and CR4 belong to the family of β2-integrins. These 
molecules are heterodimeric transmembrane glycoproteins consisting of a non-covalently 
coupled α and β polypeptide chain, which have a fundamental role in cellular adherence, 
migration and the clearance of pathogen microbes, tumour- and apoptotic cells by 
phagocytosis. Their ligands include complement components (iC3b) on the surface of 
opsonised targets, and adhesion ligands (fibrinogen, ICAM-1)1–3. 
The two receptors have a different distribution and expression pattern in mouse and 
human cells, consequently data obtained in mouse systems can only be applied for human 
immune cells with great caution7. In mice CR4 is expressed on DCs in the highest number, 
and it is often used as a marker for these cells. Recent data suggests however, that under 
inflammatory conditions mouse monocytes and macrophages also express CR4, which 
exerts antimicrobial functions227. In humans both receptors are constitutively present on 
monocytes, macrophages, DCs, neutrophils and NK cells228.  
CR3 and CR4 are generally thought to mediate similar functions due to their structural 
homology and overlapping ligand specificity. The extracellular regions of CD11b and 
CD11c display 87% similarity, but their intracellular domains, important for signal 
transduction and connection with the cytoskeleton, differ in length and amino acid sequence 
displaying only 56% identity4,5. The simultaneous presence of these receptors on leukocytes 
and their different signalling properties however suggest a separation of functions229. Our 
group set out to thoroughly investigate the roles of CR3 and CR4, since studies revealed a 
pivotal role for of these receptors in leukocyte functions necessary for the resolution of 
infections6. 
Firstly, we set out to study the participation of CR3 and CR4 in adhesion, as the 
importance of this integrin mediated function is clearly evidenced by the serious symptoms 
of pathological conditions affecting the adhesive capacity of leukocytes, like leukocyte 
adhesion deficiency (LAD)180 or Wiskott–Aldrich Syndrome (WAS)196. We used fibrinogen 
as an adhesion ligand. It is an acute phase protein that is deposited at the site of injury both 
intravascularly and in the extracellular matrix, facilitating the adhesion and activation of 
leukocytes99. Both CR3 and CR4 are capable of binding fibrinogen230, leading to a possible 
competition between the two receptors for this ligand.  
The adhesive capacity of cells was assessed by different approaches: a classical 
adhesion assay and two state-of-the-art biophysical methods. The classical method consists 
65 
 
of counting the number of cells attached to the fibrinogen coated surface, whereas the 
biophysical methods allowed us to gain information about the quality of adherence. The 
computer controlled micropipette is capable of measuring the strength of adhesion while the 
optical waveguide biosensor records adhesion kinetics. Using these techniques we 
demonstrated, that under physiological conditions CR4 is the main receptor that mediates 
strong adhesion of MDMs and MDDCs to fibrinogen. Blocking CD11c with a ligand binding 
site specific antibody decreased the number of adhered cells and the force of adhesion on 
MDMs and MDDCs, moreover, it inhibited the spreading of MDMs, resulting in a smaller 
contact area. Surprisingly, the blocking of CD11b had an opposite effect on these cell types, 
as we observed no reduction in the number of adhered cell but an enhanced spreading, and 
this larger contact area provided a stronger attachment for MDMs and MDDCs. These data 
suggest that although CR3 is able to bind fibrinogen, it can have a negative role in the 
adhesion of these two cell types. However, in the case of monocytes, both anti-CD11b and 
anti-CD11c decreased the number of cells adhered to fibrinogen and the force of adhesion.  
To resolve this contradiction we propose the following hypothesis: based on the 
absolute number of cell surface receptors6,8, adhesion to fibrinogen is dependent on the 
number and ratio of CR3 and CR4 on the cell surface. In a preliminary experiment we found 
that the number of fibrinogen ligands on the adhesive surface is comparable with the number 
of receptors found on monocytes. Since there are enough ligands available for both receptors, 
they take part equally in adhesion without a competition. This idea needs further support by 
analysing the adhesion of neutrophils, which express the two receptors in similar amounts 
to monocytes. In previous adhesion studies performed on monocytes and neutrophil 
granulocytes, both CR3 and CR4 mediated adhesion and spreading, suggesting that the 
adhesion properties of these cell types are similar80,231,232. 
 In the case of MDMs and MDDCs however, there is a competition between CR3 and 
CR4 for accessible fibrinogen ligands, because both receptors are present in high numbers. 
With the crystal structures available for the ligand binding I-domains of both receptors, 
Vorup-Jensen et al. showed a ridge of positively charged residues present only in CR4, that 
results in a differential ligand binding compared to CR3233,234. While CR3 recognizes 
molecules with a positive charge, CR4 preferentially binds polyanionic species and 
molecules with a net negative charge, such as fibrinogen. This difference in ligand binding 




Circulating leukocytes are guided to the site of injury by chemotactic signals, which 
initiates adhesion and transmigration through the endothelial cell layer235. The migratory 
capacity of MDMs and MDDCs, towards the small chemoattractant peptide fMLP, was 
assessed by a transwell assay, that simulates the active, integrin-mediated translocation of 
leukocytes through a barrier. When using ligand binding site specific antibodies, we found 
that both anti-CD11b and anti-CD11c inhibited the migration of MDMs towards fMLP, but 
the number of migrated cells was significantly lower when CR3 was blocked. In the case of 
MDDCs both receptors take part equally. The transwell assay provides a technique to 
characterize the migration of cells with the participation of all cell surface integrins. To 
investigate the specific participation of CR3 and CR4 in transmigration, further experiments 
are required using a fibrinogen coated membrane.  
CR3 and CR4 mediate cell adhesion, spreading and migration through the formation 
of cell-cell and cell-extracellular matrix connections30. To establish these contacts cells use 
specific structures, called podosomes. They are known to mediate short-lived adhesion spots 
that are formed and quickly remodelled during migration. These structures have an F-actin 
core surrounded by adhesion molecules159 and can be arranged in clusters, rings or belts161. 
Podosomes are characteristic for monocytic cells, such as monocytes, macrophages, 
osteoclasts and dendritic cells. Here we studied the podosomes of human phagocytes adhered 
to a fibrinogen coated surface. Monocytes and MDMs mostly showed an even distribution 
of podosomes scattered across the contact surface, however a belt like pattern could also be 
observed for MDMs. The podosomes of dendritic cells were found to be arranged in clusters 
or condensed in the leading edge of migrating cells. Whether human neutrophils have 
podosomes is still debated. Neutrophils isolated from mice and pretreated with fMLP formed 
podosome-like structures, containing an actin core and a vinculin ring, on fibrinogen coated 
cover slips236. In this study we detected the formation of actin rich dots evenly spread on the 
contact surface of human neutrophils adhered to fibrinogen. 
The importance of β2-integrins in podosome formation and podosome mediated 
adhesion has been proven, but the individual role of these receptors had not been studied so 
far. Burns et al. found, that β2-integrins are specifically recruited to podosomes in human 
MDDCs on a fibronectin surface (a ligand for both β1- and β2-integrins), whereas β1-integrins 
show a disperse distribution166. In a β2-integrin-null mouse model, Gawden-Bone et al. 
showed that in the absence of β2-integrins podosome assembly is disrupted167. 
Here we show that both CR3 and CR4 are located in the adhesion ring of podosomes 
in human MDMs and MDDCs attached to fibrinogen. Additionally, a strong staining for the 
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receptors can be observed intracellularly, around the nucleus. Integrins are known to rapidly 
recycle between the cell membrane and endosomes20, which can occur via distinct routes24,25. 
In the long loop of recycling integrins go through the perinuclear recycling compartment 
before returning to the cell surface27. No data is available yet on the exact recycling route 
used by β2-integrins, but the staining pattern we found around the nucleus might implicate a 
passage through the perinuclear recycling compartment. 
 
The other frequently studied role of CR3 and CR4 is the phagocytosis of complement 
opsonized microbes. In macrophages the opsonophagocytic function of CR3 has been 
proven earlier237, and also a role for CR4 was shown in the uptake of Mycobacterium 
tuberculosis by alveolar macrophages173. Though alveolar macrophages differ from 
monocyte derived macrophages due to their tissue microenvironment and cytokine milieu, 
several data show that on MDMs both CR3 and CR4 participate in the phagocytosis of 
opsonized Cryptococcus neoformans238, Mycobacterium leprae179 and Francisella 
tularensis175. These studies however do not clearly distinguish between the complement 
receptor mediated binding and digestion of the pathogens. We compared these two different 
functions using the pH sensitive pHrodo Green labelled Staphylococcus aureus and the 
classical Alexa488 conjugated particles. This approach allowed us to detect bacteria destined 
for degradation and separate those from the bound and endocytosed ones.  
Employing this method, in the case of MDMs we found a collaboration between the 
two complement receptors. Namely, we observed that blocking CR4 decreased the amount 
of surface bound particles, while the digestion of iC3b opsonized S. aureus was dependent 
on a functional CR3. However, there are data indicating the existence of two subsets of CR3 
and CR4 that can be distinguished based on lateral mobility5,239. Graham et al. showed, that 
the actin-attached, immobile subset of CR3 was responsible for the phagocytosis of iC3b 
opsonized particles, despite that the mobile subset could also bind the particles239. CR3 is 
also known to associate with other receptors, like Fcγ-receptors, uPAR and CD14240, and the 
expression and distribution of these interacting receptors can differ between cell types. The 
different mobility and interacting partners of CR3 and CR4 could influence the outcome of 
phagocytosis in a cell type specific manner.  
Our group demonstrated earlier that blocking of CD11c did not influence the uptake 
of opsonized yeast or S. aureus by MDDCs. We confirmed these results using siRNA; when 
downregulation of CD11b blocked the phagocytosis of opsonized particles while silencing 
CD11c had no effect on their uptake215. Now we have strengthened these findings by 
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showing that only CR3 blocking decreases the binding and uptake of S. aureus. In contrast 
to this Ben Nasr et al. demonstrated that blocking both CR3 or CR4 inhibited the 
phagocytosis of opsonized, live Francisella tularensis by human MDDCs241. This 
contradiction might be caused by differences in the pathogens and the capacity of live 
Francisella tularensis to utilize CR4 as well to get into the host cells. 
Studies of phagocytosis carried out employing monocytes and neutrophils underline 
the importance of CR3 expressed by these cells. Monocytes utilize CR3 but not CR4, for the 
phagocytosis of Mycobacterium tuberculosis173 and M. leprae170, similarly to neutrophils in 
the case of Francisella tularensis175. In our present study we show that in the phagocytosis 
of the extracellular pathogen S. aureus, opsonized by iC3b, CR3 plays a dominant role over 
CR4 by both monocytes and neutrophils. 
Taking our results together, we obtained further evidence that under physiological 
conditions CR3 and CR4 exert distinct functions in human phagocytes. Though both CR3 
and CR4 are able to bind fibrinogen and iC3b, we found that either of them dominates the 
other in various functions, such as antigen uptake and digestion, as well as adhesion and 
spreading.  
 
Macrophages and dendritic cells are essential in the recognition of invading 
pathogens and the initiation of immune responses. Both cell types are professional antigen 
presenting cells, but they have different roles in several aspects. Dendritic cells migrate to 
lymph nodes after antigen uptake to initiate an adaptive immune response by presenting 
these antigens to naïve T-cells242. Resident macrophages migrate within the peripheral 
tissues to the site of infection, where they take part in the elimination of pathogens by 
phagocytosis, production of reactive intermediates and the establishment of an inflammatory 
milieu by cytokine secretion243. 
In the initial phase of an immune response after tissue injury or infection immune 
cells are recruited and an inflammatory environment is established. Additionally, many 
pathological conditions are known to induce chronic inflammation, where the continuous 
activation of leukocytes contributes to tissue damage. β2-integrins are acknowledged to play 
a critical role in cell migration and the resolution of infections6. An elevated expression of 
CR3 or CR4 was shown on blood monocytes of rheumatoid arthritis patients220 and during 
hypertriglyceridemic conditions221, contributing to enhanced adhesiveness in both cases. 
These data and our previous results prompted us to investigate in more detail the expression 
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of CR3 and CR4 on macrophages and dendritic cells and dissect their adhesive and migratory 
function under inflammatory conditions. 
After the lysis of Gram-negative bacteria glycolipids from the outer membrane are 
released, that serve as potent proinflammatory stimuli for myeloid cells. Bacterial 
lipopolysaccharides (LPS) are known to bind to Toll-like receptors and β2-integrins that 
promote receptor activation and cell adhesion. Wright et al. identified an LPS binding site 
in the CR3 α chain that was distinct from the location of iC3b and fibrinogen binding73. 
Wong et al. showed two putative LPS binding sites in the β2 I-like domain244 that would 
explain why LPS binding to either LFA-1, CR3 or CR4 all induce an inflammatory 
response74,245,246. CR3 was also shown to become associated with CD14 after LPS treatment 
on neutrophils247, and that it might use the same adaptors for LPS signalling as CD14248.  
Antigen uptake and proinflammatory stimuli induce macrophage activation and 
dendritic cell maturation involving changes in the expression of costimulatory molecules, 
chemokine and phagocytic receptors249. Upon stimulation by LPS neutrophils quickly, but 
transiently upregulate the expression of CR3 from intracellular granules, and the receptors 
on the cell surface switch to high affinity conformation, both events contributing to enhanced 
adhesiveness250,251.  
In the present work we monitored the changes in the expression of CD11b and CD11c 
upon LPS stimulation. On MDMs and MDDCs treated with LPS for 30 minutes the amount 
of CD11b slightly decreased, while the amount of CD11c did not change, but after 24 and 
48 hours the amount of CD11b decreased on both cell types. At the same time the quantity 
of CD11c increased in MDDCs but was lower in MDMs, suggesting a cell type specific 
regulation. In our experiments investigating the conformation of β2-integrins, we found a 
significantly elevated amount of receptors binding mAb24 after 30 minutes of LPS 
treatment, due to the increased activation and intracellular accumulation of these receptors. 
Although this antibody is specific for an activation epitope in all β2-integrins, LFA-1 was 
shown to have a very low endocytosis rate compared to CR3, that was not influenced by 
stimulating agents20. Consequently, the observed increase in internalization and recycling 
speed can be attributed to CR3 and CR4. 
Taking these results together we demonstrated for the first time that the amount of cell 
surface CR3 and CR4 does not increase immediately after LPS treatment, but their activation 
status and recycling speed changes. Integrin activation and recycling are most likely linked 
processes, Arjonen et al. showed that active β1-integrins have a higher endocytosis rate, 
whereas receptors in an inactive state are rapidly recycled to the plasma membrane24. We 
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propose that at the early stage of LPS stimulation β2-integrin activation triggers receptor 
endocytosis and faster recycling. Thus, a higher endocytosis rate for LPS activated CR3 
could explain the decrease in cell surface expression after 30 minutes.  
Integrins are known to mediate cell adhesion, spreading and migration through the 
establishment of cell-cell and cell-extracellular matrix connections30. Our group focuses on 
clarifying the individual roles of the β2-integrins CR3 and CR4, as they are often assumed 
to have overlapping, or even identical functions. Early studies on human granulocytes and 
monocytes proved that LFA-1, CR3 and CR4 all contribute to endothelial adhesion154,155, 
and that the cell type and the stimuli used can influence the participation of these receptors. 
Georgakopoulos et al. also showed, that the involvement of CR3 and CR4 in adhesion to 
fibrinogen is dependent on the experimental conditions, namely the type of stimuli and 
culture conditions of human blood monocytes157. Earlier we demonstrated that in the lack of 
inflammatory stimulus CR4 plays a dominant role in the adhesion to fibrinogen8. 
Here, we studied the adhesive capacity of MDMs and MDDCs after LPS stimulation. 
We used both the classical, end-point adhesion assay and a computer-controlled micropipette 
method capable of measuring the force of adhesion. When applying ligand binding site 
specific antibodies we found that both anti-CD11b and anti-CD11c treatment weakened 
adhesion to fibrinogen coated surfaces, as verified by the decreased number of adherent cells 
and force of attachment. Importantly however, while both receptors participated in adhesion, 
the force of attachment was significantly lower for the anti-CD11c treated cells, proving a 
dominant role for CR4.  
This differential participation of CR3 and CR4 in adhesion confirms our previous 
hypothesis8, namely that ligand availability and the number of cell surface receptors 
regulates receptor utilization. Based on the absolute number of cell surface receptors6,8, we 
proved that there is a competition between CR3 and CR4 for accessible fibrinogen ligands 
on MDMs and MDDCs, where both receptors are present in high amounts. Since LPS 
treatment altered the cell surface expression of these receptors differently on MDMs and 
MDDCs, we detected a change in receptor usage. The number of both receptors decreases 
upon LPS treatment on MDMs, allowing the ligand binding of both CR3 and CR4. In the 
case of MDDCs the ratio of receptors shifts in favor of CR4, strengthening its dominant role.  
Emerging data on podosomes highlight their importance in myeloid cell adhesion and 
migration. Considering the differences in immune functions between macrophages and 
dendritic cells we compared the formation and β2-integrin composition of podosomes after 
inflammatory stimuli on these cell types. During LPS induced maturation dendritic cells go 
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through cytoskeletal changes, losing their capacity for phagocytosis and podosome 
formation150,166. In this study we demonstrate, that after 24 hours of LPS treatment MDDCs 
do not form podosomes on a fibrinogen coated surface, significantly lowering the force of 
adherence compared to immature cells. In contrast, MDMs preserve these structures after 
LPS activation and there is only a slight decrease in the adhesion force measured with the 
computer-controlled micropipette, proving that podosomes ensure a strong attachment. 
A crucial and specific role for β2-integrins in podosome functions has been 
demonstrated by others166,167, and we have also proven, that under physiological conditions 
both CR3 and CR4 are located in the adhesion ring of podosomes in human MDMs and 
MDDCs attached to fibrinogen174. Here we show that on LPS matured MDDCs, with the 
loss of podosomes, CD11b and CD11c are concentrated in the cell body and in membrane 
protrusions. The strong staining around the nucleus might imply that β2-integrins go through 
the perinuclear recycling compartment in the long loop of integrin cycling before returning 
to the cell surface25. In the case of LPS activated MDMs, the cells become more elongated, 
but CD11b and CD11c are localized around the actin core of podosomes, similarly to 
untreated cells.  
Our previous studies proved a “division of labour” between CR3 and CR4 under 
physiological conditions8,174, with CR3 participating in the phagocytosis of iC3b opsonized 
Staphylococcus aureus and CR4 dominating cell adhesion to fibrinogen. After LPS 
treatment the expression and role of these receptors changed, proving our hypothesis, that 
the number and ratio of cell surface receptors influences the outcome of cell-matrix 
interactions. We also found further evidence underlining the functional differences between 
macrophages and dendritic cells, and a strong indication that podosomes are essential for 




Figure 28. The function of CR3 and CR4 under physiological and inflammatory 
conditions. Our studies proved a “division of labour” between CR3 and CR4 under 
physiological conditions, with CR3 participating in the phagocytosis of iC3b opsonized 
Staphylococcus aureus and CR4 dominating cell adhesion to fibrinogen. In the process of 
migration and podosome formation of MDMs and MDDCs both receptors took part. LPS 
treatment changed the expression and role of these receptors, both CR3 and CR4 contributed 
to the adhesion, migration and podosome formation, however in the case of MDDCs CR4 
provided a stronger attachment to fibrinogen. Abbreviations: Neu: neutrophil granulocyte; 







CR3 and CR4, the leukocyte specific β2-integrins, are involved in cellular adherence, 
migration and phagocytosis.  They are often assumed to mediate similar functions due to 
their structural homology and overlapping ligand specificity. Our group set out to thoroughly 
investigate the distinct role of CR3 and CR4 in myeloid cell functions under physiological 
and inflammatory conditions.  
The adhesive capacity of monocytes, monocyte derived macrophages (MDMs) and 
dendritic cells (MDDCs) was assessed by different approaches: a classical adhesion assay 
and two biophysical methods. Using these techniques we demonstrated, that under 
physiological conditions CR4 is the main receptor that mediates strong adhesion of MDMs 
and MDDCs to fibrinogen. However, in the case of monocytes, both receptors were involved 
in adhesion, so we proposed the following hypothesis: adhesion to fibrinogen is dependent 
on the number and ratio of CR3 and CR4 on the cell surface. In the case of monocytes the 
number of receptors is comparable with the amount of available ligands, but MDMs and 
MDDCs express these receptors in higher numbers, resulting in a competition for fibrinogen.  
We studied the formation and composition of podosomes, that are characteristic 
adhesive structures of myeloid cells. We found different podosome patterns depending on 
the cell type, namely an even or belt like distribution for monocytes and MDMs, and clusters 
for MDDCs. Additionally, we showed, that both CR3 and CR4 are located in the adhesion 
ring of podosomes in the contact zone of MDMs and MDDCs attached to fibrinogen.  
The participation of CR3 and CR4 in phagocytosis, with the clear distinction between 
surface bound and internalized particles, was assessed using iC3b opsonized Staphylococcus 
aureus. Comparing the activity of the two β2-integrin type complement receptors we found 
that CR3 plays a dominant role in the phagocytosis of this pathogen on neutrophil 
granulocytes, monocytes, MDMs and MDDCs. 
To better understand the role of CR3 and CR4 in pathological conditions inducing 
inflammation, we also studied their functions on LPS activated MDMs and MDDCs. We 
found that LPS treatment alters the expression of these β2-integrins. The amount of CR3 
decreases on both cell types, whereas the level of CR4 increases in MDDCs but decreases 
in MDMs, suggesting a cell type specific regulation. Using mAb24, specific for the high 
affinity conformation of CD18, we proved that the activation and recycling of β2-integrins 
is significantly enhanced upon LPS treatment.  
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The adhesion studies on LPS treated cells confirmed our previous hypothesis, with the 
altered expression of CR3 and CR4 we detected a change in receptor usage. On MDMs the 
number of both receptors decreases upon LPS treatment, allowing the participation of both 
CR3 and CR4 in adhesion to fibrinogen. In the case of MDDCs the ratio of receptors shifts 
in favour of CR4, strengthening its dominant role. 
Studying the formation of podosomes under inflammatory conditions, we found major 
differences between MDMs and MDDCs. While MDMs retain podosome formation after 
LPS activation, MDDCs lose this ability, which results in a significantly reduced force of 
adhesion. We show that with the loss of podosomes the distribution of CR3 and CR4 







A leukocita specifikus β2-integrinek családjába tartozó CR3 és CR4 fontos szerepet 
tölt be az immunsejtek adherenciájában, migrációjában és opszonizált részecskék 
fagocitózisában. A két receptornak gyakran azonos funkciót tulajdonítanak, hiszen nagyfokú 
szerkezeti homológiát mutatnak és átfedő a ligandum specificitásuk is. Munkacsoportunk 
célul tűzte ki e két receptor egyedi funkciójának alapos vizsgálatát a mielod sejtek 
funkcióiban, mind fiziológiás, mind gyulladásos körülmények között.  
A sejtadhézió jellemzésére több különböző módszert használtunk: a klasszikus 
adhéziós esszé mellett két biofizikai módszert. Ezen módszerek segítségével kimutattuk, 
hogy fiziológiás körülmények között a CR4 kulcsszerepet játszik a fibrinogénhez való erős 
adherenciában makrofágok és dendritikus sejtek esetén. Mivel monocitákon mindkét 
receptor blokkolása gátolta az adherenciát,hipotézisünk szerint a fibrinogénhez való 
adherencia a CR3 és CR4 mennyiségétől és egymáshoz viszonyított arányától függ. 
Monocitákon a sejtfelszíni receptorok mennyisége összemérhető az elérhető fibrinogén 
ligandumok számával, viszont makrofágok és dendritikus sejtek esetén kompetíció fog 
kialakulni a két receptor között, mivel ezeken a sejttípusokon egy nagyságrenddel magasabb 
a receptorszám. 
Megvizsgáltuk a mieloid sejtekre jellemző adhéziós struktúrák, a podoszómák 
kialakulását és összetételét. Az általunk vizsgált sejttípusok esetében különböző podoszóma 
mintázatokat találtunk: neutrofilek, monociták és makrofágok felszínén egyenletes vagy 
övszerű eloszlás volt jellemző, míg dendritikus sejteknél a kisebb csoportokba rendeződés. 
Továbbá kimutattuk, hogy a fibrinogénnel fedett felszínhez kitapadt makrofágok és 
dendritikus sejtek kontakt felszínén a CR3 és CR4 megtalálható a podoszómák adhéziós 
gyűrűjének területén.  
A két receptor részvételét az iC3b-vel opszonizált Staphylococcus aureus 
fagocitózisában neutrofil granulocitákon, monocitákon, makrofágokon és dendritikus 
sejteken vizsgáltuk, egyértelműen elkülönítve a felszínhez kötődött és internalizált 
részecskéket. Az összes sejttípus esetén a CR3 domináns szerepét igazoltuk ennek a patogén 
baktériumnak a fagocitózisában.  
A CR3 és CR4 gyulladással járó patológiás körülmények közötti szerepének 
feltérképezésére a két receptor szerepét LPS aktivált makrofágokon és dendritikus sejteken 
is megvizsgáltuk. LPS kezelés hatására a receptorok sejtfelszíni expressziója megváltozott. 
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A CR3 mennyisége mindkét sejttípuson csökkent, míg a CR4 szintje nőtt makrofágokon, de 
alacsonyabb lett dendritikus sejteken, bizonyítva a két receptor expressziójának 
sejtspecifikus szabályozását. A CD18 lánc aktív konformációjára specifikus mAb24 
ellenanyag használatával kimutattuk, hogy az LPS kezelés fokozza a β2-integrinek 
aktivációját és reciklizációját.  
Az LPS aktivált sejteken végzett adhéziós kísérletek alátámasztották hipotézisünket, 
amennyiben a receptorok módosult expressziójával a szerepük is megváltozott. 
Makrofágokon a CR3 és CR4 mennyisége is csökkent LPS kezelés után, és mindkét receptor 
részt vett az adherenciában. A receptorok mennyisége dendritikus sejteken ellentétesen 
változott, eltolva az arányukat a CR4 javára, megerősítve a receptor domináns szerepét az 
adherenciában.  
A podoszómák megjelenésében jelentős különbségeket találtunk makrofágok és 
dendritikus sejtek esetében gyulladásos körülmények között. Míg makrofágok esetén az LPS 
kezelés után is megtalálhatók ezek a képletek, a dendritikus sejtek elveszítik a képességüket 
a podoszómák létrehozására, és ez szignifikánsan lecsökkenti kitapadásuk erejét. 
Podoszómák hiányában a CR3 és CR4 eloszlása is megváltozik, inkább a sejttest körül és 
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